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ABSTRACT
CHARACTERIZATION OF GENE EXPRESSION REQUIRED FOR
PREIMPLANTATION EMBRYO DEVELOPMENT
SEPTEMBER 2013
MARC P. MASERATI JR., B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Jesse Mager
Preimplantation embryo development in the mouse is a time of rapid cellular
morphological and molecular changes leading to embryo implantation for the generation of
offspring. The Mager lab studies these events occuring between fertilization and implantation in
order to better understand the initial events which set the stage for all future aspects of
development. The result of this research impacts many scientific disciplines including in-vitro
based means of embryo culture, establishment of epigenetic marks, differentiation and cellular
reprogramming and can be used in translational research for the improvement of in-vitro culture
techniques and develop novel therapies such as cell replacement in the case of macular
degeneration (Bin, L., 2009).
Through the use of in-vitro embryo culture, RNA interference (RNAi) approaches and
daily observations, gene function required in preimplantation embryo development can be
determined. In the initial published body of work evaluating gene knockdown using our RNAi
approach (Maserati M 2011), WDR74 was characterized in preimplantation embryo
development. We now understand that WDR74 is implicated in RNA production and/or
v

stability as gene knockdown at the 1 cell stage significantly depletes mRNA within the embryo
by the morula stage. Furthermore, double knockdown of Trp53 and Wdr74 results in a partial
rescue of blastocyst formation suggesting p53 mediated apoptosis in the failure to make a
blastocyst phenotype.
The initial characterization of 4 RNA processing genes (SF3b14, SF3b1/SAP155, Rpl7l1
and Rrp7a) required for blastocyst formation was later evaluated. The results of this work has
been submitted for publication and will be published soon in the journal Zygote. SF3b14 and
SF3b1, identified as being part of the splicesome complex, disproportionally contributes to gene
transcription of those genes containing more than 1 exon verifying a role in RNA splicing.
Rpl7l1, identified by GO terms as a possible ribosomal gene, was found to be present in the
cytoplasm and, surprisingly, in the nucleus. It is surmised this gene influences polymerase 2
activity as Rpl7l1 gene knockdown embryos demonstrate reduced active polymerase 2 activity at
the morula stage. Rrp7a was identified as being critical in blastocyst formation and is present in
the cytoplasm while excluded from the nucleus. Based on location and GO terms, this suggests a
role in translation. Taken together, these 4 genes act in 3 different ways impacting RNA
production, splicing or translation promoting blastocyst formation in the mouse.
The final gene evaluated in this work was Bcl-6 corepressor (Bcor). As opposed to our
previous work with RNA processing factors, this gene knockdown does not result in a failure to
make a blastocyst. Bcor knockdown increases the rate of physiologically normal blastocysts in
both murine and bovine models. Although further characterization must be done, temporary
Bcor gene knockdown might be a useful improvement of in-vitro embryo culture systems
including murine, bovine, equine and possibly even human.
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This manuscript is divided into 4 chapters, the first of which is a review of
preimplantation embryo development. This covers selected and relevant events between
fertilization and just before implantation of the embryo into the uterus. I mainly focus on events
after fertilization and the necessary changes required for zygotic genome transcription and
lineage specification.
The second chapter characterizes WDR74, a gene we identified as critical in the
formation of a blastocyst in a reverse genetic screen. As state before, we assess WDR74
function with the developing embryo and conclude the protein plays a role in RNA production
and/or stability of RNA transcripts. We also test to rescue blastocyst formation in WDR74
knockdown embryos in an attempt to further evaluate WDR74 function.
We continue the characterization of genes whose temporary reduction causes the failure
of blastocyst formation in the third chapter. Here we report on four additional RNA processing
genes in a body of work which has been published in the journal Zygote. Since these genes
contained similar GO terms, we assumed they may all function in a similar way so they were
assayed together as a group. As function of these genes were unknown, we determined protein
localization within the cell, function in RNA splicing, alternative splicing and to determine if the
failure to make a blastocyst is due to lineage specification.
In the final chapter, BCOR gene expression is characterized in preimplantation embryo
development as in the former 2 chapters. However, the result of this gene knockdown does not
lead to the failure to make a blastocyst, rather this improves the number of blastocysts formed
during the correct physiological time; the same time that blastocysts form invivo. Undoubtedly,
this could lead to possible commercial applications which are reviewed along with the
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preliminary data we have been able to collect thus far. Specifically, the continuation of the
BCOR gene knockdown research in preimplantation embryo development is pitched in the form
of academic and international business collaboration with InvitroBrasil for the production of
cloned bovine, equine and ICSI in equine.
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CHAPTER 1
INTRODUCTION
1.1 Preimplantation Embryo Development
Preimplantation embryo development is a carefully orchestrated series of events initiating
with fertilization and concluding with formation of the blastocyst (Rossant, J 2009).
Mammalian oocytes differ in terms of timing with the events of ovulation, oocyte nuclear and
cytoplasmic maturation, fertilization and preimplantation embryo development; all more or less
follow this ordered series of events with the exception of the dog (Reynaud, K 2006, Tadros, W
2009 and Rossant, J 2009). Therefore to understand mammalian embryo development in one
species is to have a basic understanding of other mammalian species.
Fertilization is initiated with the sperm head fusing with the oocyte membrane and
releasing a protein (PLCz) in to the oocyte cytoplasm which initiates a calcium release from the
endoplasmic reticulum. This results in an oscillating calcium gradient which persists in a
repeating degrading pattern until the first cell division (Malcuit, C 2006). The calcium signal
initiates resumption of meiosis, formation and extrusion of the second polar body and cortical
granule exocytosis to inhibit polyspermy. (Yoon, SY 2007; Ross,P 2009). The sperm haploid
genome is released into the environment of the oocyte cytoplasm. The paternal nuclear material
within the sperm is organized using protamines within the sperm to conserve space and ensure
stability. Once in the oocyte, histones replace the protamine coincident but not because of the
initiation of paternal genome demethylation at the one cell stage (Sassone-Corsi, P 2002) and
(Santos, F 2002) and soon after forms the pronucleus.
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Meanwhile in the maternal genome, upon resumption of meiosis the second polar body is
released reducin the maternal genome to haploid. The 2 pronuclei join to form a new 2N
genome called syngamy. The cell cycle then advances to the 2 cells stage where the embryo
continues its rapid paternal genomic demethylation followed by a gradual maternal
demethylation. Upon reaching the blastocyst stage, remethylation occurs in the ICM in a
lineage specific manner (Santos, F 2002).
From the time of oogenesis until just after fertilization, protein production within the
oocyte originates from the maternal RNA. The embryo genome is transcriptionally silent.
Gradually, the embryo recruits and degrades maternal RNA transcripts in favor of transcripts of
zygotic origin using the RISC complex to selectively degrade RNA transcripts of maternal
origin. RNA transcription from the embryo, zygotic genome activation (ZGA), commences
initially within the male pronucleus at the 1 cell stage with complete transcription by the 2 cell
stage and throughout the genome as well (Schultz, RM., 2002).

The cell cycle continues in

development until the morula stage where lineage specification occurs.
1.1.1 Lineage specification
Post fertilization, the cell cycle resumes with even, reductive divisions until the blastocyst
stage. As the embryo attains 16-32 cells, reorientation of blastomeres coincident with altered
gene expression begins to distinguish 2 distinct cell types. The inner cells continue to express
pluripotency genes with the addition of Nanog. The outer cells begin to express Tead4 and later,
CDX2 which works to reduce Oct4 transcription. These differences become much more
pronounced during the transitions between the morula and blastocyst stage as the hydrogen
pumps activate transforming the compact ball of cells into a expanded structure with distinct
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internal and external structures. This is accomplished by the development of tight gap junctions
and ion channels which import sodium ions into and potassium out of the expanding blastocyst.
(Watson AJ., 2001). Thus, the initial cell differentiation event has taken place and is called
lineage specification. Successful lineage specification results in a defined inner cell mass (ICM),
trophectoderm (TE) and later the primitive endoderm (PE) (Cockburn, K 2010). These cells
produce known mutually exclusive protein products and can be visually differentiated from each
other using antibodies specific to these proteins via immunofluorescence. Cells of the ICM
maintain expression of OCT4, SOX2 and NANOG expression while the outer TE cells produce
TEAD4 and CDX2. The proteins produced by the ICM maintain pluripotency while TE
expression of Cdx2 represses pluripotency genes leading to differentiation from the totipotent
state. Mutually exclusive expression of OCT4 and CDX2 in the ICM and TE respectively
signify completion of lineage specification (Cockburn, K 2010). While the ICM will develop
into tissues used of embryo proper and specific extraembryonic membranes, the TE and PE will
almost exclusively contribute to extra-embryonic tissues (Kwon, G 2008).
1.1.2 X-Chromosome inactivation
Somatic female cells contain 2 X-chromosomes, while males only contain 1. In order to
compensate for the 2 fold increase in genes, female mammalian cells undergo a process called
dosage compensation in which one X-Chromosome is rendered nearly transcriptionally inactive.
The inactive X-chromsome was first observed in female feline motor neurons; described as a
“Barr body” a dense heterochromatin mass closely associated with the nucleus (Barr, ML 1949).
The Barr body was later to be recognized as the inactive X chromosome (review in Morey, C
2011). During preimplantation embryo development, female embryos at the 4 cell stage will
begin to undergo paternal X-chromosome inactivation. By the blastocyst stage, the TE cells will
3

maintain the inactive paternal X– chromosome while the ICM will undergo paternal Xchromosome activation followed quickly by random X-chromosome inactivation (Kalantry, S.,
2011). This is mediated by expression of 2 transcripts, Xist and Tsix which inactivate or activate
transcription of the chromosome from which the RNA products originate (Ohhata, T., 2011).
These transcripts are initiated by cis or trans activating factors such as in the case of RNF12
activation of Xist transcription (Barakat, T 2011) which acts through degradation of the
pluripotency factor Rex1 (Gontan, C 2012). Xist functionally inactivates the chromosome from
which it is expressed by physically coating the inactive X chromosome with the Xist RNA
transcript (Brown, CJ 1992)(reviewed in Kalantry, S 2011).
1.2 Reverse genetic screen
1.2.1 Introduction
This research endeavors to identify novel critical gene function during preimplantation
embryo development by selectively reducing transcripts in using an RNAi approach and
observing developmental phenotypes. Although there are several genome wide knockout
programs currently ongoing (Guan, C 2010) (Austin, P 2004), this research differs from those
attempts through the evaluation of gene function and are not limited to the determination of
knockout lethal phenotypes.

A reverse genetic screen was developed by Dr. Jesse Mager to

study developmental and epigenetic events in preimplantation embryo development. The
following sections describe the approach and implementation of the reverse genetic screen.
1.2.2 Candidate gene selection
The initial step in this screen was to identify genes of interest. As expression array data
is accessible through on-line databases, a computer based screen was performed evaluating gene
4

expression over 3 different developmental stages using pooled expression array data. Pooling
gene expression array data has been shown to increase reliability in expression array data
(Mager, J 2006). The developmental stages evaluated in the expression arrays were arranged as
follows; metaphase II until the 2 cell stage, 4 cell to the 16 cell stage, and early expanding
blastocyst to late expanding blastocyst stages.

Gene expression was then evaluated to identify

those genes with a dynamic expression pattern as a temporal increase in expression may point to
a critical function at this embryonic stage in development. Gene expression was determined
absent or present (A or P) depending on the threshold of gene expression. As there are 3
different developmental stages defined, combinations of PPA, is indicative of high gene
expression earlier on in development which tapers off at the blastocyst stage. This could indicate
function in zygotic transcription initiation.

APP indicates low gene expression in the initial

stages of preimplantation embryo development while increasing at the 8 cell and blastocyst
stages. This could indicate a function in blastocyst formation. Although there are 9 possible
combinations, only 7 were used as AAA and PPP were omitted from consideration.
1.2.3 RNAi gene knockdown via microinjection
Knockdown of individual genes at the one cell stage was accomplished through the use of
pulled glass pipets backloaded with dsRNA specific to the gene of interest. A Nikon Diaphot
Mounted with eppendorf electrical micromanipulators held fine pulled pipets used for
micromanipulation. dsRNA was injected into a secondary chamber formed by a larger than
usual holding pipet which allows more volume to be introduced into the embryo as well as
considerably reducing embryo lysis during injection (Figure 1). This secondary chamber is
created through the deformation of the zona pellucida and oolemma as the holding pipet begins
to aspirate the oocyte into the holder (Figure 1 C). The needle tip can then cut through the zona
5

pellucida and positioned within the inner chamber (Figure 1 C). A gentle piezo pulse will allow
cutting of the oolemma at the tip and not along the sides of the needle minimizing the risk of
lysis. dsRNA then displaced the cytoplasm in the chamber. The needle is quickly removed
allowing the oolemma to reform intact (Figure 1 D). The reformation of the oolemma is helped
by 2 factors based on the geometry of the secondary chamber. First, the elongation of the
embryo allows the oolemma more surface area to interact, increasing the probability of
reformation. Furthermore, due to the force of the dsRNA being introduced into the embryo and
displacement of the cytoplasm, the outer edges of the oolemma are brought together increasing
the probability of reformation. If done properly, lysis can be less than 1-2% of embryos injected
which compares favorably with current techniques whereby 25% lysis is expected. (Nagy, A
2003).
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Figure 1: Images of murine PN stage embryo microinjection

A

B

C

D

E

Images of murine PN stage embryo microinjection A) Selection of a PN stage embryo B) Pipet
entering through the zona pellucida C) Positioning of the pipet into the secondary chamber just
prior to microinjection D) Microinjection of dsRNA into the secondary chamber E) Completed
microinjection.

1.2.4 Initial knockdown screen results
The initial screen identified 1200 genes which displayed a dynamic pattern of gene
transcription. After eliminating genes which were already well characterized in preimplantation
development or had obvious housekeeping functions, 400 were selected to be knocked down in 1
cell embryos in groups of 4-5 pooled dsRNAs. After injection, the embryos were evaluated daily
for development up until the blastocyst stage to determine if the gene knockdown inhibited
blastocyst formation or outgrowth. Those injected groups which resulted in a morphological
change in development were chosen for further evaluation by evaluating lineage specification,
zygotic genome activation and other gene specific assays to determine function. The initial
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screen identified 29 genes which caused either a failure to make a blastocyst or if attained the
blastocyst stage, failed to make an ES-like outgrowth in-vitro (Table 1).

Table 1: Functional groups of genes identified in the initial reverse genetic screen
Results of the reverse genetic screen Number of genes
Failure to make an outgrowth
14
Stem cell factors
2
Epigenetic factors
3
RNA factors
3
Protein factors
0
Other factors
6
Unknown factors
4
Failure to make a blastocyst
Stem cell factors
Epigenetic factors
RNA factors
Protein factors
DNA factors
Unknown factors

15
0
1
7
5
2
1

Identified Genes
Cxros1, Tbl1xr1
Suv39h1, Ube2a, Bcor
Puf60, Ptcd3, Asf1b
Tuba1a, Arg1
1110003E01Rik, 17000250:D13Wsu50e
1190002J23Rik, 1110054005Rik

Nop2
Mxi1,Rpl7l1, Rrp7a, Sf3b1, Sf3b14, Wdr74
Uspl1, Itgae, P4Ha2/P4H1, Rtn4, Pbrm1
Dck,Matr3
Mfng

The distribution of outgrowth failure genes into groups based on function was somewhat
evenly spread out between pluripotency, epigenetics and RNA production. As this group of
genes are not required for making a blastocyst, their critical function could be implicated in
differentiation, signal transduction, or cell migration as these functions are essential in the post
implantation embryo. Interestingly, there were 6 factors which were completely unknown in
function based on gene ontology (GO) terms and pubmed searches.
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Among the genes characterized by failure to make a blastocyst, there was a bias towards
RNA factors and protein modifying factors, basic functions required for cell division and
development.
For my thesis research we characterize Wdr74 in preimplantation embryo development in
chapter 2. Knockdown of this gene results in a failure to make a blastocyst and we evaluate how
this failure occurs. This body or work resulted in a publication (Maserati, M 2011). In the third
chapter, we investigate 4 RNA processing genes starting from the research platform used in the
Wdr74 work to branch off into this further work. Finally in chapter 4 we investigate Bcor gene
knockdown in preimplantation embryo development.

9

CHAPTER 2
WDR74 IS REQUIRED FOR BLASTOCYST FORMATION

2.1 Introduction
Preimplantation is a dynamic developmental period in which a combination of maternal
and zygotic factors program the early embryo resulting in lineage specification and implantation.
A reverse genetic RNAi screen in mouse embryos identified the WD Repeat Domain 74 gene
(Wdr74) as being required for these critical first steps of mammalian development. Knockdown
of Wdr74 results in embryos that develop normally until the morula stage but fail to form
blastocysts or properly specify the inner cell mass and trophectoderm. In Wdr74-deficient
embryos, we find activated Trp53-dependent apoptosis as well as a global reduction of RNA
polymerase I, II and III transcripts. In Wdr74-deficient embryos blocking p53 rescues blastocyst
formation and lineage differentiation. These results indicate that Wdr74 is required for RNA
transcription, processing and/or stability during preimplantation development and is an essential
gene in the mouse
Preimplantation development in the mouse is a time of dynamic change in which the
fertilized egg becomes a pluripotent embryo that subsequently develops into a blastocyst with
two distinct cell lineages. This developmental period is characterized by three major transitions,
each of which entails pronounced changes in the pattern of gene expression. The first transition
is the maternal-to-zygotic transition (MZT) that serves three functions: (1) to destroy oocytespecific transcripts, (2) to replace maternal transcripts that are common to the oocyte and early
embryo with zygotic transcripts and (3) to facilitate the reprogramming of the early embryo by
10

generating novel transcripts that are not expressed in the oocyte (Latham, KE 1991). Zygotic
gene activation initiates during the late 1-cell stage at some genes and throughout the genome by
the 2-cell stage (Latham, KE. 1991), (Schultz,G 1993) . Coincident with genome activation is the
acquisition of a chromatin-based transcriptionally-repressive state (Nothias, JY 1995) ( Schultz,
RM 2002) and more efficient use of TATA-less promoters (Majumder S., 1994), which are
likely to play a major role in establishing the appropriate patterns of gene expression required for
proper development.
Up to the 8-cell stage, individual blastomeres are loosely associated. During compaction,
adhesive interactions form between blastomeres to generate a tightly organized mass of cells
(Fleming,TP 2001) . Accompanying this morphological transition are pronounced biochemical
changes through which blastomeres acquire characteristics resembling somatic cells, reflected in
such features as ion transport, metabolism, cellular architecture, and gene expression patterns.
The appearance of gap and tight junctions at the late 8-cell stage results in an epithelium that is
essential for proper development (Fleming, TP 2001) (Kidder, GM 2001) .
Following compaction, cleavage divisions allocate cells to the inside of the developing
morula. These inner cells of the morula give rise to the inner cell mass (ICM) from which the
embryo proper is derived. The outer cells differentiate exclusively into the trophectoderm (TE),
which generates extraembryonic tissues. The TE is a fluid transporting epithelium that is
responsible for forming the blastocoel cavity, which is essential for continued development and
differentiation of the ICM (Biggers, DJ 1988) Watson, AJ 1990) . Overt cellular differentiation
first occurs in the blastocyst and is characterized by differences in gene expression between the
ICM and TE cells. For example, expression of Pou5f1 (Oct4) and Fgf4 (Nichols, J 1984) (
Niswander, L 1992); Pesce, M 2001) become restricted to the ICM, while expression of Bex1,
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the imprinted H19 gene and Cdx2, an ortholog of the Drosophila homeotic Caudal (Cad) gene,
are restricted to the TE in the preimplantation embryo (Beck, F 1995) (Doherty, AS 2000)
Williams, JW et al. 2002). Proper specification of these distinct lineages is required for
blastocyst formation and facilitates hatching from the zona pellucida and implantation into the
uterine epithelium reviewed in(Cockburn and Rossant 2010) .
In order to expand our understanding of the genes required for these critical
developmental events, we initiated an RNAi based screen during mouse preimplantation. Based
on the simple assumption that a dynamic change in a given gene’s expression level may be
indicative of temporal specific function, we analyzed published micro-array data sets (Hamatani,
T 2004); (Zeng, F 2004) and ( Zeng,F 2005) for genes with dynamic expression patterns
during preimplantation stages. We first used an unbiased insilico approach to merge published
data sets in order to select genes based on preimplantation expression pattern alone, irrespective
of associated gene ontology (Mager, J 2006). Genes with known roles during preimplantation
and genes known to be required for cell viability were then removed as candidates. We next
tested the preimplantation requirement of each of the remaining candidate genes by
microinjection of gene-specific long double-stranded RNAs (dsRNAs) into fertilized 1-cell
zygotes and subsequent culture in vitro to the blastocyst stage, an approach which has been used
successfully during preimplantation and does not elicit an interferon response or significant offtarget effects (Stein, P 2005) . We maximized our screening potential through injection of pools
of up to 5 different dsRNAs in order to knockdown 5 separate genes simultaneously. Pooled
dsRNAs that resulted in a phenotype were then injected singly to determine the gene responsible.
Here we present data showing that the WD Repeat Domain 74 gene (Wdr74) is required during
preimplantation development.
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Wdr74 is characterized by six WD40 repeats, which are minimally conserved structural motifs of
approximately 40 amino acids that often terminate in a tryptophan-aspartic acid (WD) dipeptide
(Smith, TF 1999). To date, no studies have functionally characterized Wdr74. Analysis of the
predicted Wdr74 protein using functional domain finding algorithms reveals no identifiable
functional domains, besides the WD repeats, providing little insight. Wdr74 is a single copy gene
that is very well conserved across mammalian species with all vertebrates having one
orthologous locus of at least 77% amino acid identity(Berglund, AC., 2008); (Penel, SA 2009) .
Interestingly, there are no homologous loci in mammals with significant amino acid similarities
besides the WD repeat domains, indicating the unique nature of Wdr74. Although very little is
known about Wdr74, the superfamily of WD40 repeat proteins have been implicated in a wide
variety of cellular functions, such as cell division, cell fate determination, gene transcription,
transmembrane signaling, mRNA modification, and vesicle fusion (Neer, EJ 1994). The function
of WD-repeats has been shown to mediate protein-protein interactions during complex assembly
(Lee, D 2001) possibly explaining the wide array of functions that are ascribed to genes
containing them. Additionally, the importance of WD-repeat proteins is evident: the sequence
has been conserved across all species in eukaryotes (reviewed in (Li,L 2001)) , and WD repeat
motifs have also been identified in prokaryotes as well (Janda, L., et al. 1996), (Hisbergues,
M.,et al. 2001). Here, we present data describing the developmental and molecular
consequences of loss of Wdr74 function.
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2.2 Procedures for Wdr74
2.2.1 Embryo Production and collection
B6D2F1 females (Jackson Laboratories, Stock# 100006) received an intra-peritoneal
injection of pregnant mare serum gonadotropin (PMSG; 5 IU/animal), followed by stimulation
with human chorionic gonadotropin (hcG; 5 IU/animal) 48 hours later. Mice were mated with
B6D2F1 males. Embryos (0.5dpc) were collected via flushing the infundibulum with M2
medium.
2.2.2 Microinjection
Injection and holding micropipettes were pulled from borosilicate capillary tubes with a
Sutter p-87 glass puller (Sutter Instruments). The injection needle tip was cut to make a 1-2μM
diameter opening and the needle was then bent to 15o using a microforge (DeFronbrun).
Microinjection was performed using a piezo impact-drive injector (PrimeTech) mounted on a
Diaphot inverted microscope (Nikon) with Hoffman Modulation Contrast objectives and
condenser. Micromanipulation of embryos was performed using TransferMan NK 2
(Eppendorf,) in M2 medium (Chemicon) with 0.01% PVP (Sigma). Each embryo was injected
with approximately 5pL dsRNA. After all embryos were injected, they were transferred into
microdrops of M2 medium for 10 minutes at 37C before deposition in KSOM medium for
extended culture.
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2.2.3 Embryo Culture
Embryos were cultured in 35mm petri dishes (Falcon) in 30-50L drops of KSOM
(Chemicon) under 3mL mineral oil (Fisher Scientific) in 5% CO2, 5%O2 and 90% N2 at 37oC in
a humidified incubator.
2.2.4 dsRNA in vitro transcription
For T7-RNA polymerase mediated double stranded RNA (dsRNA) production, Wdr74,
Trp53 and Green Fluorescent Protein (GFP) specific PCR primers were designed using 40 basepair oligos that contained the T7 binding sequences followed by gene specific sequences as
follows: GfpF 5’- TAATACGACTCACTATAGGGCACATGAAGCAGCACGACTT -3’ and
GfpR 5’-TAATACGACTCACTATAGGGTGCTCAGGTAGTGGTTGTCG-3’, Wdr74F 5’ TAATACGACTCACTATAGGGCGGAATGATTGGCTTGATCT -3’ and Wdr74R 5’ TAATACGACTCACTATAGGGAGGGTACTTGGTTGGGCTCT -3’ ; Trp53F 5'
TTATACGACTCACTATAGGGCACGTACTCTCCTCCCCTCA-3' and Trp53R 5'TAATACGACTCACTATAGGGTACCTTATGAGCCACCCGAG -3'. All oligos were
purchased from IDT. dsRNAs were created using the MEGAscript T7 in vitro transcription kit
(Ambion) followed by DNase treatment (Roche) and purification using NucAway Spin Columns
(Ambion) and Phenol/Chloroform extraction. dsRNAs were re-suspended in Nuclease-Free
water (Integrated DNA Technologies) and diluted to 400ng/µL for microinjection. dsRNA was
stored at -80oC until use.
2.2.5 Pyronin Y RNA staining
Embryos were fixed in 4%PFA for 10 minutes, rinsed twice in PBS with 0.3% PVP
(PBS/PVP) and stained in PBS/PVP Hoechst (IDENT Hamilton Thorne) 40µg/mL for 10
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minutes. Embryos were then directly transferred to PBS/PVP 5μM Pyronin Y (ACROS) for 10
minutes. The embryos were then rinsed three times in 400L PBS plus 0.3% PVP before being
mounted in VectaShield (Vector Labs) on glass slides and evaluated for epifluorescence with a
TE2000S inverted microscope (Nikon). All photographs were taken using a Retiga EXi camera
(Photometrics) using National Instruments Elements (National Instruments) image capture
software under phase contrast and epifluorescence.
2.2.6 RNA Quantification
The Agilent RNA 6000 Pico kit was used according to manufacturer’s recommendations.
RNA was extracted from embryos using the High Pure RNA Isolation Kit (Roche) and
resuspended to 1.6 embryo equivalents per microliter (EE/L). Samples were run in triplicate.
RNA concentration was also assessed by NanoDrop spectrophotometer according to
manufacturers’ instructions.
2.2.7 RNA isolation and cDNA synthesis
Total RNA was extracted from single and pooled embryos using the High Pure RNA
Isolation Kit (Roche) according to manufacturer’s recommendations. First strand cDNA was
prepared from total RNA using the qScript cDNA Synthesis Kit (Quanta) according to the
manufacturers’ instructions.
2.2.8 Quantitative Real-Time PCR
Real-time RT-PCR was performed using 0.75 embryonic equivalents with Taqman probe
based gene expression assays from Applied Biosystems as follows: 2X Quanta PerfeCTa
Supermix Low ROX, 20X Vic-labeled ActB (#4352341E) or GapD (#4352339E), 20X Gene
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Expression Assay (Bax Mm00432050_m1; miR-125 TM002198; miR-721- #TM001657; Oct4
Mm00658129_gH; Tead4 Mm01189836_m1; Trp53 Mm01731287; Wdr36 Mm00620161_m1;
Wdr74 Mm00506573_m1; Rnu6 TM1973; Sno110 TM1230
Snord65 TM1228; Mvp Mm00453676_m1) and water to total 20L. Reactions were run in
triplicate on a Stratagene Mx3005p Real-Time PCR machine with a thermal profile of: 1 cycle of
50C for 30 seconds, 1 cycle of 95C for 2 minutes, then 40 cycles of 15 seconds at 95C and 30
seconds at 60C.
2.2.9 Reverse-Transcriptase PCR
PCR was performed using 0.75 embryonic equivalents, 2X RubyTaq mastermix, 10mM
of both forward and reverse primers, and water to total 20L. The Wdr74 forward primer used
was 5’ CGGAATGATTGGCTTGATCT 3’ and the reverse primer was 5’
AGGGTACTTGGTTGGGCTCT 3’. PCR reactions were performed in a Biorad MyCycler
machine for 35 cycles of 95°C for 30 seconds, 60°C for 30 seconds, 72°C for 30 seconds with a
final extension of 2 minutes at 72°C.
2.2.10 Immunofluorescence
Embryos were fixed in 4% paraformaldehyde for 30 minutes at room temperature,
washed three times in phosphate buffered saline (PBS) containing 0.1% Tween-20, and
permeabilized with PBS containing 1% TritonX-100 for 30 minutes at room temperature.
Embryos were then blocked for 1 hour at room temperature in 2% bovine serum albumin (BSA)
in PBS. Primary antibodies were added in appropriate dilutions [1:200 rabbit anti WDR74
(Sigma SAB1102237); 1:50 rabbit anti-Trp53 polyclonal (Cell Signaling Technologies), 1:200
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rabbit anti-Ecadherin polyclonal (Abcam), 1:200 rabbit anti-Oct4 polyclonal (Abcam), 1:200
mouse anti-Cdx2 monoclonal (BioGenex), 1:200 rabbit anti-H3K4me3 polyclonal (Abcam),
1:200 Rabbit Anti-Fibrillarin (Abcam, ab5821), 1:100 Rabbit Anti-CTD PolII (Abcam, ab5095)]
in PBS/BSA (2%) for 1 hour at room temperature. After the embryos were washed three times
with PBS containing 0.1% Tween-20, secondary antibodies (Alexa Fluor 546 Anti Rabbit –
Molecular Probes A-11035; Alexa Fluor 488 Anti Rabbit – Molecular Probes A-21206; Alexa
Fluor 488 Anti Mouse – Molecular Probes A-11001) were added at a 1:200 dilution in PBS/BSA
and incubated for 1 hour at room temperature. 4’,6-Diamidino-2-phenylindole (DAPI) was used
as a marker to stain nuclear DNA at a concentration of 1:10,000 for 10 minutes, then the
embryos were washed three times with PBS containing 0.1% Tween-20, and mounted in water
under VWR micro cover glass. As negative controls, embryos were treated similarly, without
primary antibodies. Embryos were imaged using a Retiga EXi camera (Photometrics) using
National Instruments Elements (National Instruments) image capture software under phase
contrast and epifluorescence.
2.2.11 Blastomere Counting
Double-blind cell counting was repeated by two individuals using DAPI-stained nuclei
and the NIS Elements BR software.
2.3 Results
2.3.1 Wdr74 is required for blastocyst formation
In order to determine the temporal expression of Wdr74 during preimplantation
development, we used both quantitative reverse-transcriptase PCR (qRT-PCR, Figure 1A) and
intron spanning qualitative RT-PCR (Figure 2B) to visualize endogenous mRNA levels at
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various preimplantation stages. As shown in Figure 2, Wdr74 is expressed at relatively low levels
in MII oocytes and 1-cell embryos and increases through subsequent cleavage stage divisions.
The peak of mRNA expression occurs at the morula stage, with a slight decrease in blastocyst
embryos (Figure 2A), suggesting a key function during the morula to blastocyst transition.
Additionally, immunofluorescence with an antibody directed against human WDR74 showed no
specific signal until the 8 cell stage in wild type embryos (not shown), when weak nuclear
localization is observed. In morula and blastocyst, Wdr74 is evident within nuclei of all cells
(Figure 2K). This pattern of protein expression perfectly correlates with the endogenous RNA
levels, and suggests no Wdr74 function until late 8cell/early morula stages.
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Figure 2: Wdr74 is required for blastocyst formation

A. Quantitative RT-PCR analysis of endogenous Wdr74 mRNA during preimplantation development. B. RT-PCR
with Wdr74 intron-spanning primers confirms relative abundance of transcripts observed by qRT-PCR. C-H.
Microinjected and cultured embryos photographed at 36, 60, and 84 hours post fertilization. Control dsGFPinjected embryos show normal development and form blastocysts by 84 hpf (C-E). dsWdr74 injected embryos
develop normally to the morula stage (F-G) but fail to make blastocysts (H). I. Quantification of percent 2 cell
embryos that develop to the blastocyst stage by 84 hpf (# blastocysts/ # 2-cell x 100). J. qRT-PCR of Wdr74
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transcripts indicates robust RNAi mediated knockdown due to microinjection of dsWdr74. K.
Immunofluorescence of Wdr74 in morula stage dsGFP embryos shows nuclear localization; which is drastically
reduced in dsWdr74 embryos of the same stage (L). hpf, hours post fertilization. Results of student T-test
shown, error bars represent standard deviation. All data shown normalized to embryo equivalents; MII,
Metaphase II oocyte. Scale bar in F representative for C-H. K’ and L’ show DAPI signal (DNA) from the
same embryos shown in K and L, respectively.

In order to remove Wdr74 activity, we injected dsWdr74 RNA into the cytoplasm of 1cell embryos. In all experiments presented, control embryos were injected with dsGFP in order to
similarly stimulate the RNAi machinery and show specific effects of loss of Wdr74. Wdr74
knockdown embryos (hereafter referred to as dsWdr74 embryos) were able to compact and
develop normally to the morula stage with no obvious differences in morphology or rate of
development compared to controls (compare Figure 2C and D with F and G). By 84 hours post
fertilization in culture (hpf), 91% (89/98) of control embryos have initiated blastocoel formation
(Figure 1E and I). However, only 4% (4/110) of the dsWdr74 embryos showed any evidence of a
blastocoel cavity (Figure 1H,I). The majority of dsWdr74 embryos showed visible signs of
degeneration by 84 hours post fertilization (necrotic and irregular cells, Figure 2H).
We confirmed robust knockdown of dsWdr74 by qRT-PCR with cDNA from pooled
control and experimental embryos at the morula stage (Figure 2J). Furthermore,
immunofluorescence showed drastic reduction in dsWdr74 morula stage embryos indicating
functional knockdown of Wdr74 (compare Figure 2K and L), and consistent reduction of both
mRNA and protein using this approach. As stated above, dsWdr74 embryos appear
morphologically normal through the morula stage. However, immunofluorescence revealed that
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the blastomeres of dsWdr74 morula have reduced E-Cadherin protein present at cell-cell contacts
and appear somewhat disorganized relative to controls (compare Figure 3A-C and D-F).
Nonetheless, the appropriate localization of E-cadherin suggests that knock-down morula
blastomeres are contacting each other appropriately in preparation for compaction and cavitation.
Consistent with a peak in Wdr74 activity during the morula to blastocyst transition (Figure 2),
these results indicate that a molecular and cellular phenotype is present in dsWdr74 morula, 1
day before the embryos degenerate.

2.3.2 Lineage specification and apoptosis in dsWdr74 morula
In order to explore possible reasons for the blastocyst failure and embryo death we
examined markers of lineage specification and apoptosis. As shown in Figure 2C, we find an
overall decrease in both Oct4 and Tead4 transcripts, known markers of ICM and TE, respectively
(results shown relative to embryo equivalence). Importantly, we also observe a reduction in the
“housekeeping” transcripts, -actin and Gapdh, within dsWdr74 embryos (Figure 3C). The
reduced transcript levels could be the result of either reduced mRNA or reduced cell numbers per
embryo. Counting of cells in dsGFP and dsWdr74 morula revealed no reduction in cell number
in dsWdr74 morula (Figure 3D), suggesting either global reduction of transcription or a loss of
mRNA due to defects in stability and/or processing of nascent transcripts.
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Figure 3: Gene expression in dsWdr74 morula

A-B. E-cadherin (Cdh1) localization by immunofluorescence marks blastomere cell-cell adhesion as expected in
dsGFP morula (A). E-Cadherin is appropriately localized but present at reduced in dsWdr74 morula (B). C. qRTPCR assays show reduced RNA polymerase II derived transcripts of Pouf51, Tead4, Act, GapdH, Bax, and Cdh1
but Trp53 shows an increase in transcripts in Wdr74-deficinet embryos. D. The average number of cells in dsGFP
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and dsWdr74 morula is not significantly different. E-F. Localization of Trp53 by immunofluorescence shows a
marked increase of Trp53 protein in dsWdr74 embryos (compare F to E), consistent with the increase in Trp53
mRNA. Results of student T-test shown, error bars represent standard deviation. All data shown normalized to
embryo equivalents. N.S., not significant. Scale bar in B and F representative for A-B and E-F, respectively.

Consistent with the blastomere cell death observed at 84hours, we find an increase in
transcripts of the apoptotic marker Trp53 (p53) in dsWdr74 morula (Figure 3C). However, we
did not observe a similar increase in Bax levels, a gene thought to be downstream of Trp53
(Miyashita, S 1994) . Instead, Bax transcripts show a similar decrease in abundance as Oct4,
Tead4, Gapdh and -actin. Supporting the qRT-PCR results, we observe increased Trp53
protein within the cells of dsWdr74 morula (compare Figure 3E and F).

2.3.3 Co-injection of dsWdr74 and dsTrp53 permits blastocyst formation
Because Wdr74-deficient embryos showed increased levels of p53, we attempted to block
apoptosis by knocking-down p53 by co-injection of dsWdr74 and dsTrp53. Reduction of p53 in
dsWdr74 embryos rescued blastocyst formation in 49% of embryos (Figure 4A-C). For this
experiment we added an additional control of injecting dsTrp53 alone, which had no adverse
consequences on development to the blastocyst stage (data not shown). All injection groups
(dsGFP, dsWdr74, dsTrp53 and dsWdr74/dsTrp53) developed normally to the morula stage.
qRT-PCR confirmed expected knockdown in each group (Figure 4D). As expected, dsWdr74
embryos failed to form blastocysts and remained at the morula stage with obvious morphological
signs of dying cells. However, 49% (34/69) of the dsWdr74/dsTrp53 co-injected embryos were
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able to successfully form blastocoel cavities with morphologically distinct ICM and TE cells
during the culture period (asterisks, Figure 4B). This rescue of blastocyst formation (from 4% to
49%) suggests that dsWdr74 knockdown embryos are capable of differentiating ICM and TE
cells, but fail to do so due to Trp53-induced apoptosis. However, immunofluorescent staining
shows that the majority of TE cells in these “rescued” blastocysts express both Oct4 and Cdx2
(arrows, Figure 5) indicating that although morphological differentiation has occurred, molecular
patterning has not been properly established. Furthermore, many cells within the ICM of
dsWdr74/dsTrp53 blastocysts inappropriately express Cdx2. Consistent with reduced transcript
levels in the absence of Wdr74, the levels of both Oct4 and Cdx2 protein were reduced in
dsWdr74/dsTrp53 embryos. Many of these double knockdown “rescued” blastocysts contain
morphologically abnormal and/or necrotic cells, indicating that while blastocyst formation does
occur, viability was not rescued. It is also worth noting that Wdr74/Trp53-deficient blasts do not
expand as wild type embryos do, and remain in “early” blastocysts stages, reminiscent of the
Cdx2 null embryo phenotype, which form early blasts but fail to maintain epithelial integrity of
the TE (Strumpf, D 2005) .
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Figure 4: Blocking Trp53 permits blastocyst formation in Wdr74-deficient embryos

A-B. Morphological evaluation of dsWdr74-injected and dsWdr74 + dsTrp53 co-injected embryos at 84 hpf.
dsWdr74 embryos do not develop past the morula stage (A). Reduction of Trp53 permits differentiation of Wdr74deficient blastocysts (B). C. Percent of 2-cell embryos reaching the blastocyst stage by 84hpf in dsGFP, dsWdr74
and dsWdr74 + dsTrp53 co-injected embryos. D. qRT-PCR confirms knockdown of Wdr74 and Trp53 as expected.
Results of student T-test shown, error bars represent standard deviation. All data shown normalized to embryo
equivalents.

26

Figure 5: Lineage specification in dsWdr74/dsTrp53 blastocysts

A-H. Immunofluorescence localizes Oct4 and Cdx2 to the inner cell mass and trophectoderm, respectively, in
dsGFP embryos (A-E). In dsWdr74/dsTrp53 rescued blastocysts (2 shown, F-J and K-O), Cdx2 is expressed and
Oct4 is reduced (but present) in some TE-like cells (arrows in F-O). Scale bar in K representative for all panels.
DIC, differential interference contrast microscopy.

2.3.4 Global reduction of RNA in Wdr74 deficient embryos
Based on the observation of reduced transcripts of all genes examined (except Trp53)
when Wdr74 is knocked-down (Figure 3), we assessed global RNA levels in morula stage
embryos using Pyronin Y, a fluorescent molecule that binds RNA (Shen, H 2008) . We find a
drastic decrease in Pyronin Y fluorescence in morphologically normal dsWdr74 morula at 60hpf,
indicating a significant reduction of RNA in Wdr74-deficient embryos (compare Figure 6A and
B). It is worth noting that approximately 8 hours earlier (~52 hpf), no qualitative differences
were detectable in Pyronin Y fluorescence, suggesting a rapid decrease in RNA at the time when
dsWdr74 embryos begin to compact. To confirm and quantify these results, RNA was extracted
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from equal numbers of dsGFP and dsWdr74 embryos (50 each) and assessed using a
Bioanalyzer. As shown in Figure 5C, 18S and 28S peaks are clearly observed in RNA extracted
from dsGFP injected embryos at the morula stage. However, these peaks are entirely absent in
RNA extracted from Wdr74-deficient morula (Figure 6D).
2.3.5 RNA quantification via Bioanalyser and Polymerase III transcription
As with the qPCR assays, we used equal numbers of embryo equivalents in order to
compare dsGFP and dsWdr74 samples. For the Bioanalyzer results shown, precisely 1.7 embryo
equivalents of total RNA was used for both dsGFP and dsWdr74, in triplicate (Figure 5C and D).
Consistent with reduced but not absent gene specific transcripts (Figure 2C), many minor peaks
are present in the electropherogram from the dsWdr74 extracted RNA, indicating that some RNA
is present. Given these results, we also assessed RNA samples with a Nanodrop
spectrophotometer, which indicated an extraction of ~5.8ng total RNA from each dsGFP morula,
while only ~0.66ng was recovered from each dsWdr74 embryo. This reduction in total RNA is
consistent with the qPCR results that show between 2 and 5-fold reduction of gene specific
transcript
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Figure 6: Global loss of RNA in dsWdr74 embryos

A-B. Hoechst 33322 (blue) and Pyronin Y (red) stains bind to DNA and RNA, respectively, in dsGFP (A) and
dsWdr74 (B) embryos. Note the dramatic decrease in Pyronin Y fluorescence in the absence of Wdr74. C-D.
Bioanalyzer electropherograms from total RNA extracted from dsGFP (C) and dsWdr74 embryos (D) show that 18s
and 28s ribosomal RNAs are nearly absent in Wdr74-deficient embryos. E. Relative levels of microRNAs miR-125
and miR-721 and RNA polymerase III derived transcripts, Mvp, Rnu6, Snord110 and Snord65 in dsGFP and
dsWdr74 morula. Results of student T-test shown, error bars represent standard deviation. All data shown
normalized to embryo equivalents.

29

Since we observed reduction of transcripts generated by both RNA polymerase I
(ribosomal RNAs) and RNA polymerase II (coding transcripts in Figure 2), we also assessed
levels diverse types of RNA species. We examined two microRNAs (mir-125 and miR-721)
expressed during preimplantation (Yang, Y 2008) and four RNA polymerase III dependent
transcripts, major vault protein (Mvp), U6 small nuclear RNA (Rnu6) , and two small nucleolar
RNAs [Snord110 and Snord65 (Das,G 1988); Kickhoefer, VA 2003) . Consistent with a global
RNA reduction, we observe significant decrease of all of these gene products in dsWdr74
embryos (Figure 5E).
2.4 Discussion of results and conclusions
Here we have shown the molecular and developmental consequences of loss of Wdr74
function in vivo. Our results indicate that Wdr74 is required during preimplantation development
and suggest that this poorly studied protein plays an essential role in global RNA transcription,
processing and/or stability across the genome. We observe a similar reduction of transcripts
produced by all RNA polymerases (I, II and III) suggesting that Wdr74 may be a common
protein component of all three polymerase complexes. Interestingly, a human WD containing
protein, Wdr92, has been identified in as a common component of RNA polymerase complexes
(reviewed in (Cloutier, P 2010). Furthermore, we observe reduction of both intron-containing
and single-exon transcripts, indicating that the global reduction is not due to a failure of premRNA splicing which has also been shown required for blastocyst formation (Latham, KE
1991; Yonemasu,R 2005) . Similarly, RNA polymerase I deficient embryos develop to morula
that fail to form blastocysts (Chen, Li 2008) , supporting the possibility that Wdr74 is an
essential component of RNA polymerase complexes.
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The increase in Trp53 mRNA and protein indicates that the basic cellular processes of
transcription, mRNA processing and translation can (and does) occur in the absence of Wdr74. It
does remain possible that Wdr74 is absolutely required for transcription or translation but that
there is sufficient Wdr74 protein present at the time of mRNA knockdown to allow for
transcription and/or translation of Trp53, a possibility consistent with the reduction, but not
absence of Wdr74 protein in knockdown embryos. However, we do observe Cdx2 protein, albeit
at reduced levels in dsWdr74/dsTrp53 embryos. Cdx2 protein is not consistently present at high
levels in blastomeres until late morula/early blastocyst stage (Ralston, A 2008) . This is
precisely when we observe strongest reduction in Wdr74 transcripts in dsWdr74 embryos. Given
that we do observe Cdx2 protein in Wdr74 deficient cells of “rescued” blastocysts (Figure 4), we
conclude that Wdr74 function is not absolutely required for transcription or translation.
Similarly, we observe reduced but present E-cadherin protein, which is required during
preimplantation for blastomere compaction and formation of functional TE (Riethmacher, D
1995). The reduction in E-cadherin may be one contributing factor of the failure to form
blastocysts, as it is also required for a properly polarized TE (Kan, NG. 2007) . However,
because dsWdr74 blastomeres appropriately localize E-cadherin and knockdown embryos do
compact normally, we believe that the reduction in E-cadherin is a consequence – not a cause of
the phenotype in Wdr74-deficient embryos.
Another possible explanation for the reduction of RNA could be defects in nucleolus
function/structure. We do not observe morphological defects in nucleolus formation or size
based on visual morphology or Fibrillarin localization (not shown), nor do we observe overt
cellular defects prior to day 3 in culture, the time at which dsWdr74 embryos have failed to form
blastocysts. The fact that we observe a reduction in all transcripts and protein during a stage
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when dsWdr74 embryos appear morphologically normal suggests that Wdr74 is essential during
preimplantation for RNA transcription, processing or stability and that as proteins degrade below
functional thresholds, Wdr74-deficient blastomeres undergo Trp53 dependent apoptosis. The
rapid reduction of RNA coincident with Trp53 activation occurs at the precise developmental
stage when we observe the highest Wdr74 transcript levels in wild-type embryos. As we do not
observe appreciable levels of maternal transcripts or protein, our results indicate that Wdr74 is
not required until the morula-to-blastocyst transition.
While the precise mechanism of Wdr74 remains to be determined, our results offer the
following conclusions: 1) Wdr74 is expressed from the zygotic genome and is required for
morula to blastocyst transition; 2) In the absence of Wdr74 function there is a global reduction
of RNA transcripts from RNA polymerase I, II and III; 3) Loss of Wdr74 activates Trp53
dependent apoptosis; 4) When Trp53 function is blocked, dsWdr74 embryos are capable of
morphological differentiation and blastocyst formation although molecular patterning of lineage
specification remains defective.

32

CHAPTER 3
IDENTIFICATION OF 4 GENES REQUIRED FOR BLASTOCYST FORMATION
This work is published and can be found:
Maserati, M., Dai, X., Walentuk, M., Mager, J., (2012) Identification of four genes required for mammalian
blastocyst formation. Zygote Dec 5:1-9

3.1 Introduction
Although genome wide transcriptome studies are readily available for many tissues and
cell types, functional annotation of the entire mammalian genome remains a daunting challenge.
Several consortium based genome wide knock out and mutagenesis projects are well underway,
with the goal of generating mutant alleles for every gene in the mouse (Guan, C 2010), (Austin,
CP 2004). While these resources are immensely valuable and continue to produce data through
large-scale phenotype screening efforts, usually they will not functionally assess genes during
development other than to document lethality when an essential gene is abrogated. We have
undertaken an RNAi based screen during mouse preimplantation, aimed at identification of
genes involved in epigenetic and developmental events during the first cell lineage decisions in
vivo. During the initial phase of this screen we have identified many genes required for
blastocyst formation. In an effort towards functional genome annotation, here we characterize
four genes that are each essential during the morula to blastocyst transition in the mouse. This
report documents the preimplantation requirement of Splicing Factor 3b, subunit 1 (Sf3b1 also
called SAP155 and Sf3B155); 0610009D07Rik (hereafter called by the human orthologue gene
name, Sf3b14, but also called HSPC175, Ht006, P14, SAP14, Sf3b14a)); Ribosomal RNA
Processing 7 homolog A (S. cerevisiae, Rrp7a); and Ribosomal Protein L7-like 1 (Rpl7l1).
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Sf3b1 has been shown in vitro to be an integral member of both the major and minor
spliceosome and binds to both sides of the pre-mRNA branch site (Gonzani, O 1998), (Wang, C
1998) and (Das, BK 1999) . Sf3b1 regulates ceramide Bcl-x alternative splicing through binding
to ceramide-responsive RNA cis-element 1 in pre-mRNA, preventing splicing and resulting in a
exon inclusion (Massiello, A 2006). Mice homozygous for a knock out allele of Sap155 die at
16-32 cell stage, and interestingly, heterozygotes show homeotic transformations which are
rescued in an Mll null background (Isono, K 2005). U2snrp/Sf3b1 have been shown to interact
with polycomb group genes ZFP144 and RNF2 (Isono, K 2005) possibly explaining the
homeotic transformations due to shifts in hox gene expression boundaries. Although morula
stage lethality was noted by Isono et. al, limited characterization of the preimplantation
phenotype was performed (Isono, K 2005).
While genome wide expression analyses suggest that Rpl7l1 transcripts are increased in
the early gastrula organizer and during pancreas differentiation (Hoffman, BG 2008), (Tamplin,
OJ 2008), there are currently no published reports specifically on Rpl7l1 function. Similarly, the
Rrp7a and Sf3b14 genes have been annotated in cDNA sequencing projects (Okazaki, Y 2002),
(Kawai, J 2001), but remain functionally undocumented.
Here, we report the preimplantation expression patterns of Sf3b14, Sf3b1, Rpl7l1, and
Rrp7a and show that each is required for the morula to blastocyst transition. In the absence of
each protein, cell fate decisions are initiated, suggesting cell lethal phenotypes rather than
specific developmental requirements of these factors. We also report that zygotic transcription
does initiate, but reduced mRNA and protein levels of several genes occurs in the absence of
Rpl7l1 and Rrp7a suggesting critical functions in mRNA translation and/or ribosome function
during mammalian development. We also present data indicating an overall decrease in multi34

exon transcript levels in the absence of Sf3b14 and Sf3b1, confirming a role in RNA splicing for
these genes in vivo.
3.2 Procedures
3.2.1 Embryo Production and collection
B6D2F1 females (Jackson Laboratories Stock 100006) received an intra-peritoneal
injection of pregnant mare serum gonadotropin (PMSG; 5 IU/animal), followed by stimulation
with human chorionic gonadotropin (hcG; 5IU/animal) 48 hours later. Mice were mated with
B6D2F1 males. The following morning, females were removed from the stud cages and
examined for the presence of a vaginal plug. If a plug was present, embryos (0.5dpc) were
collected via dissection of the ampula in M2 medium followed by 5 minutes in 0.1%
Hyualronidase (Sigma) All animal studies were approved by the Animal Care and Use
Committee, University of Massachusetts.
3.2.2 Microinjection and Embryo Culture
To create the microinjection needle (injector), borosilicate capillary tubes (Sutter
Instruments) were pulled with a Sutter p-87 glass puller (Sutter Instruments) creating a fine
tapered point. The needle tip was cut to make a 1-2μM diameter opening and the needle was
then bent to 15o using a microforge (DeFronbrun). This needle was back filled with Mercury
and rinsed with 10% PVP (Sigma) prior to use. The embryo holding glass needle (holder) was
created using the same borosilicate capillary tubes and pulled as above, cut at 85μM, fire
polished and bent to 15 degrees. Microinjection was performed using a piezo impact-drive
injector (PrimeTech) mounted on a Diaphot inverted microscope (Nikon) with Hoffman
Modulation Contrast objectives and condenser. Micromanipulation of embryos was performed
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using TransferMan NK 2 (Eppendorf,) in M2 medium (Chemicon) with 0.01% PVP (Sigma).
Each embryo was injected with approximately 5pl dsRNA. Following microinjection, embryos
were transferred into microdrops of M2 medium for 10 minutes at 37C. Embryos were
transferred to and cultured in 35mm petri dishes (Falcon) in 30-50μl drops of KSOM
(Chemicon) under 3ml light mineral oil (Fisher Scientific) in 5% CO2, 5%O2 and 90% N2 at
37oC in a humidified incubator.
3.2.3 dsRNA Production
For T7-RNA polymerase mediated double stranded RNA (dsRNA) production, Sf3b14,
Sf3b1, Rpl7l1, Rrp7a and Green Fluorescent Protein (GFP) specific PCR primers were designed
using 40 base-pair oligos that contained the T7 binding sequences followed by gene specific
sequences as follows: GFP TAATACGACTCACTATAGGGCACATGAAGCAGCACGACTT
and TAATACGACTCACTATAGGGTGCTCAGGTAGTGGTTGTCG; Rpl7l1
TAATACGACTCACTATAGGGGCTTTGGAGGTGCCTGATAA and
TAATACGACTCACTATAGGGGGAGGAAAGGGCACAGAAAT; Rrp7a
TAATACGACTCACTATAGGGCACCTTGTGAAGAGCGGAAT and
TAATACGACTCACTATAGGGTCTGTGAAGGCCAAATCCTC; Sf3b1
TAATACGACTCACTATAGGGTGTGGAGTTGGCAAACAAAG and
TAATACGACTCACTATAGGGCATACAGCACCACACCCAAG; Sf3b14
TAATACGACTCACTATAGGGCGAAGGCGATCAGGTTTAGA and
TAATACGACTCACTATAGGGGGGAGGATCTGTGTTGATGC. PCR products were
amplified from genomic DNA and purified. dsRNAs were created using the MEGAscript T7 in
vitro transcription kit (Ambion) followed by DNase treatment (Roche), purification with
NucAway Spin Columns (Ambion) and then Phenol/Chloroform extracted. dsRNAs were re36

suspended in Nuclease-Free water (Integrated DNA Technologies) and diluted to 1µg/µL for
microinjection. dsRNA was stored at -80oC until use.
3.2.4 RNA extraction and quantitative PCR
RNA extraction was performed with Roche High Pure RNA Isolation Kit (Roche).
cDNA was synthesized with both random hexamers and oligo-dT primers as described
previously [12]. Real-time RT-PCR was performed using 0.75 embryonic equivalents with
Taqman probe based gene expression assays from Applied Biosystems as follows: 2X Quanta
PerfeCTa Supermix Low ROX, 20X Vic-labeled ActB (#4352341E) or GapD (#4352339E), 20X
Gene Expression Assays (Oct4 Mm00658129_gH; Cdx2 Mm01212280_m1; Nanog
Mm01617761_g1 ; Sf3b1 Mm00473100_m1; Sf3b14 Mm01310843_m1; Rpl7l1
Mm00786031_s1; Rrp7a Mm00780551_s1 ; Peg3 Mm00493299_s1 ; Snrpn Mm02391920_g1)
and water to total 20L. Reactions were run in triplicate on a Stratagene Mx3005p Real-Time
PCR machine with a thermal profile of: 1 cycle of 50C for 30 seconds, 1 cycle of 95C for 2
minutes, then 40 cycles of 15 seconds at 95C and 30 seconds at 60C.
3.2.5 Fixation, embedding, sectioning
Preimplantation embryos were embedded in a pellet of NIH 3T3 cells and prepared for
histology by fixation in 4% paraformaldehyde (PFA) for 2 hours at room temp or overnight at
4C. Embryos were dehydrated through a series of ethanol washes; 15 minutes each in 25%,
50%, 75% ethanol diluted in phosphate buffered saline (PBS), followed by two 100% ethanol
washes. Embryo/cell pellets were embedded and sectioned as previously described (Griffith, GJ
2011).
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3.2.6 Immunohistochemistry
Sections were deparaffinized with three 5-minute xylene washes and rehydrated with
three 5-minute washes in 100% ethanol, followed by successive 1-minute washes in 90%, 80%,
70% ethanol and then water. Antigen retrieval was performed by boiling for eleven minutes in
0.01M Tris Base pH 10.0 with 0.05% Tween20. After slides cooled to room temperature they
were washed twice in PBT for 2 minutes and blocked with 0.5% milk in PBT for two hours at
room temperature in a humidified chamber. Primary antibody was applied in 0.05% milk/PBT
overnight at 4C in a humid chamber. Three 15-minute PBT washes preceded a 1-hour secondary
treatment at 1:500 in 0.05% milk/PBT in a humid chamber at room temperature. Slides were
washed in PBT for 15 minutes twice and then in PBS for fifteen minutes. Nuclei were stained
with DAPI (Roche or Molecular Probes) in PBS (1:10,000) for 10 minutes and then rinsed with
PBS. Slides were sealed and coverslipped with Prolong Gold (Invitrogen). Primary antibodies
were used at the following concentrations: Phospho-p53 9284 Cell Signaling 1:200; Sf3b14
AP48076 AbGent 1:200; Sf3b1(SAP155) ab39578 abcam 1:200; Pol II phosphoS2 ab5095
abcam 1:200; Rpl7l1 16707-1-AP Proteintech Group 1:200; and Rrp7a sc-86109 Santa Cruz
1:200. AlexaFluor 488 Donkey anti-rabbit A21206 (molecular probes) was used as secondary
antibody at 1:500.
3.2.7 Whole mount embryo immunofluorescence
Whole mount preimplantation embryo IF was performed as previously described12.
Primary antibodies were used at the following dilutions: Oct4 sc-5279 Santa Cruz 1:200, Nanog
RCAB0002P-F Cosmo Bio Co 1:200, Cdx2 AM392-5M BioGenex 1:1000. Secondary
antibodies from Molecular Probes were used at 1:500: AlexaFluor 546 Donkey anti-goat
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A11056, AlexaFluor 488 Donkey anti-rabbit A21206, AlexaFluor 488 Donkey anti-mouse
A21202 and AlexaFluor 546 Donkey anti-mouse A10036.
3.2.8 Imaging
Digital images of whole mount embryos and sectioned embryos were taken with a Nikon
Eclipse TE2000-S inverted fluorescence microscope and QImaging Retiga Exi Fast 1394 camera
with NIS-Elements BR Software.
3.3 Results and Discussion
3.3.1 Sf3b14, Sf3b1, Rpl7l1, and Rrp7a required for blastocyst development
Single cell zygotes were microinjected with double-strand RNA (dsRNA) specifically
designed in order to functionally knock-down (KD) each gene. While dsGFP injected control
embryos develop normally to the blastocyst stage (Figure 7 A), injection of dsSf3b14 (B and K),
dsSf3b1 (C and L), dsRpl7l1 (D and M) and dsRrp7a (E and N) resulted in nearly complete
failure of blastocyst formation. Interestingly, embryos developed from 1 cell to morula without
any observed morphological or developmental differences, including formation of compacted
morula at 72 hours post fertilization (hpf). Despite the normal appearance at 72 hpf, KD of each
of these four genes resulted in visibly degenerating embryos at 96hpf, when dsGFP control
embryos had developed to the blastocyst stage (Figure 7 A-E).
Given the rapid and complete failure of blastocyst formation, we first asked if functional
knock down of these critical factors results in increased apoptosis. Although Trp53 (p53) protein
is present in blastomeres of the normal preimplantation embryo, it is present in its inactive form.
IF detection with an antibody specific to active p53 (phosphorylated at serine 15) indicates
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apoptosis has been initiated in many (but not all) blastomeres in dsSf3b14, dsSf3b1, dsRpl7l1
and dsRrp7a embryos (compare Figure 7F to 7G-J).

Figure 7: Sf3b14, Sf3b1, Rpl7l1 and Rrp7a are required for blastocyst formation

Evaluation of developmental progression at 24 (2-cell stage), 48 (8-cell stage), 72 (morula stage) and 96 (blastocyst
stage) hours post fertilization, following microinjection of double stranded RNAs designed to target Sf3b14 (A),
Sf3b1 (B), Rpl7l1 (C) and Rrp7a (D). Note the morphologically normal progression until the compacting morula
stage but failure to develop into blastocysts in each case. Consistent with apparent death of knock-down embryos at
96hpf, p53 is activated in many blastomeres indicating apoptosis (compare F with G-J). Quantification of blastocyst
formation (K-N). Error bars represent SEM. Asterisks indicate T-test p values <0.01. Number of microinjected
embryos are indicated for each group in charts K-N.
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3.3.2 Gene knockdown confirmation and temporal gene expression
Since KD embryos failed to develop past the morula to blastocyst transition, we next
sought to determine the normal expression pattern of each gene and validate gene specific KD.
As shown in Figure 8A, Sf3b14 transcripts are barely detectable in ovulated oocytes (MII), 1cell, 2-cell and 4-cell embryos, with a rapid rise in gene expression occurring between 8-cell,
morula and blastocyst stages. Sf3b1 shows a similar expression profile, although appreciable
maternal transcripts can be detected in the oocyte and zygote (Figure 8B). Rpl7l1 is not detected
in MII or zygote stages, and steadily increases in expression levels from the 2-cell through
blastocyst stage (Figure 8C). Rrp7a expression closely resembles that of Sf3b1, being present in
the oocyte, reduced during cleavage stages, and then increasing dramatically during the morula
and blastocyst stages. The dynamic expression profiles of identified genes was a criteria for
candidate gene inclusion in our knock-down screen – the peak of expression in morula/blastocyst
implies functional importance at that developmental window, and matches the observed
blastocysts failure phenotypes observed.
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Figure 8: Wild-type expression patterns and knockdown validation of Sf3b14, Sfb31, Rpl7l1
and Rrp7a

RT-qPCR results show dynamic expression of each gene during preimplantation development (A-D). Quantitative
assessment of knock-down efficiency resulting from gene specific dsRNA injection shows robust loss of mRNA for
each targeted transcript (E-H). Detection of endogenous proteins by IF in control and KD embryos at the 8 cell stage
show nuclear localization of Sf3b14 (I), Sf3b1 (K), nucleolar localization of Rpl7l1 (M) and cytoplasmic
localization of Rrp7a (O). KD embryos show drastic reduction/absence of protein (J, L, N, and P). Error bars
represent SEM. Asterisks indicate T-test p values <0.01.
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Microinjection of dsSf3b14, dsSf3b1, dsRpl7l1 and dsRrp7a resulted in a drastic
reduction of endogenous mRNA (figure 8E-H) and near complete loss of each protein at the 8cell stage (figure 8I-P). We also confirmed mRNA knockdown at 72 and 96 hpf (data not
shown) to ensure functional loss throughout the culture period, with similar results, indicating
loss of gene function through 96 hpf. In addition to KD confirmation, IF on control embryos
provided cellular localization information for each of these proteins, which has not been
previously demonstrated in vivo. Sf3b14 and Sf3b1 are both uniformly localized to the nucleus
in 8-cell embryos, with exclusion from the nucleolus (Figure 8I and K). Sf3b14 and Sf3b1 are
thought to interact with each other in splicesome complexes (Schellenberg, MJ 2011) so the
similar cellular localization supports these findings.
Rpl7l1 is also localized to blastomere nuclei, but appears in small foci concentrated
specifically in or around the nucleolus – but not elsewhere within each nucleus (Figure 8M).
Quite different from localization of the other three proteins, Rrp7a is found throughout the
cytoplasm and is excluded from the nucleus of 8-cell blastomeres (Figure 8O). Gene ontology
suggests that both Rpl7l1 and Rrp7A are functional components of ribosomes (Ashburner, M
2000). While the cytoplasmic localization of Rrp7a is consistent with this possibility, the
nucleolar localization of Rpl7l1 suggests a non-ribosomal function of this protein. IF detection
in knock-down embryos shows severely reduced/absent protein resulting from each dsRNA
microinjection (Figure 8J, L, N and P), consistent with the reduction of each mRNA (Figure 8EH). Given that we observe loss of protein at the 8-cell stage, it is interesting to point out that no
developmental defects appear until the morula to blastocyst transition, 24-48 hours after we
detect protein reduction. Together, these results suggest that the critical cellular functions of
these gene products are not required until after morula compaction has occurred, or that there are
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sufficient molecular redundancies of protein function (perhaps maternal components) that persist
until the blastocyst stage.
3.3.3 Lineage specification in KD embryos
Blastomeres begin to molecularly differentiate at the 8-cell/morula stage into cells of the
future inner cell mass (ICM) and trophectoderm (TE). Given the failure of KD embryos to form
blastocysts, we assessed expression genes known to mark the future ICM and TE in order to ask
if the absence of these four proteins disrupts cell fate decisions in the early embryo. All
blastomeres initially express the Pou domain transcription factor, Pou5f1 (also known as Oct4),
which becomes restricted to ICM cells coincident with expanded blastocyst formation (Nichols, J
1998) During early morula stages, the caudal-type homeodomain transcription factor, Cdx2,
becomes variably expressed, with “Cdx2 low” cells marking the future ICM, and “Cdx2 high”
cells marking the future TE (Strumpf, D 2005). Coincident with the variable expression of TE
specific genes such as Cdx2 and Tead4 during the compacted morula stage, other ICM specific
genes such as the homeodomain protein Nanog (which marks the future epiblast) are also
variably expressed in individual blastomeres ( Chambers, I 2003), (Dietrich, JE 2007) and
(Mitsui, K 2003). Although normal blastomeres show uncoordinated and variable levels of these
critical factors during the morula to blastocyst transition, mutually exclusive expression of
Oct4/Nanog and Cdx2 is not observed until the late/expanding blastocyst stage (Strumpf, D
2005), (Dietrich, JE 2007) and (Plusa, B 2008) . Due to the failure of blastocyst formation and
obvious embryo death at 96hpf, we could not assess cell lineage at a stage when cells have
mutually exclusive expression patterns. We did however assess the onset of lineage commitment
by examining Oct4, Nanog, Cdx2 mRNA levels and protein localization in compacting morula in
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order to determine if individual blastomeres show the expected variability in protein levels and if
lineage specific transcription has been activated in KD embryos.
Figure 9: Lineage specification in the absence of Sf3b14, Sfb31, Rpl7l1 and Rrp7a

IF analysis of key lineage specific proteins Nanog, Cdx2 and Oct4 in KD embryos (A-J). RT-qPCR analysis of the
same gene mRNAs in KD embryos (K). Error bars represent SEM. Asterisks indicate T-test p values <0.05.
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As expected, at 72hpf we observe Oct4 and Nanog in all wild type blastomeres as well as
a few cells with markedly higher Cdx2 levels in wild type morula (Figure 9A and F). Knock
down of Sf3b14 or Sf3b1 did not alter the protein localization of Oct4, Nanog or Cdx2, and we
do observe variable levels of Nanog and Cdx2 in individual blastomeres (Figure 3B-C, G-H).
However, the overall levels of both Nanog and Cdx2 are reduced relative to wild type controls,
and many fewer “Cdx2 high” blastomeres are apparent in either dsSf3b14 or dsSf3b1 embryos.
Knockdown of Rpl7l1 resulted in undetectable levels of Nanog and much reduced Cdx2 and
Oct4 (Figure 9D and I). Similarly, knock down of Rrp7a resulted in very low levels of Nanog
and Cdx2, although Cdx2 high/Oct4 low cells are obvious in dsRrp7a morula (Figure 9J). The
presence of Cdx2 high/Oct4 low blastomeres suggests that dsSf3b1 and dsRrp7a embryos have
functionally initiated TE lineage specification, while dsSf3b14 and dsRrp7a embryos have not
(due to the absence of Cdx2 high/Oct4 low blastomeres).
Since each of these genes is implicated in cellular functions required for molecular gene
expression (splicing or translation), we also assessed Oct4, Nanog, and Cdx2 mRNA levels in
knockdown morula (Figure 9K). Consistent with only minor reduction in Oct4 protein observed
by IF, Oct4 mRNA is modestly reduced in all KD morula. Also consistent with the reduction in
Nanog and Cdx2 observed by IF in each case, both Nanog and Cdx2 are significantly reduced in
all KD embryos.
The dramatic loss of transcripts suggests that the underlying defects resulting in
blastocyst failure in KD embryos is likely due to defects in essential molecular biological
processes, rather than a failure of specific developmental events. We therefore focused on the 8cell stage to evaluate the cell biological consequences of loss of function of these genes, a
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developmental time at which loss of protein has already occurred (Figure 8), but no obvious
morphological phenotype is present.
3.3.4 RNA polymerase II activity and RNA abundance in KD embryos
In order to assess global transcriptional activity, we performed IF with an antibody that
specifically detects RNA Polymerase II phosphorylated at serine 2 in the C-terminal domain, a
post-translational modification that marks initiating polymerase (Komarnitsky, P 2000). As
Sf3b14, Sf3b1, Rpl7l1 and Rrp7a proteins are implicated in post-transcriptional events (splicing
or translation), we did not expect to observe differences in active Pol II levels or nuclear
localization – which was the case for dsSf3b14 and dsRrp7a embryos (Figure 10 A,B and E).
Surprisingly, we observed a reduction in active Pol11 in dsSf3b1 embryos (Figure 10C), and a
near-complete absence of phospho-ser5 Pol II in dsRrpl7l1 embryos (Figure 10D). Combined
with the unexpected nuclear localization of Rpl7l1 (Figure 8M), our results implicate Rrpl7l1
either in phosphorylation of Poll II, polymerase complex formation or initiation of transcription.
This observation also explains the reduction in all transcripts that we observe in dsRrpl7l1
embryos; without active Pol II, a reduction in all Pol II dependent mRNAs would be expected.
We next asked if zygotic transcription was occurring in KD embryos by assessing mRNA
levels of Peg3 and Snrpn, both maternally imprinted loci expressed exclusively from the paternal
genome (Komarnitsky, P 2000), (Szabo, PE 1995) and (Kuroiwa, Y 1996) . All Peg3 and Snrpn
transcripts after the 2-cell stage originate from the paternal allele and therefore serve as an
indication of active transcription from the zygotic genome. Reduced but appreciable levels of
both Peg3 and Snrpn transcripts are present in all KD embryos at the 8-cell stage. At the morula
stage both Peg3 and Snrpn levels are further reduced in dsSf3b14, dsSf3b1, dsRpl7l1 and
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dsRrp7a embryos. These results indicate that although transcription from the zygotic genome is
occurring during cleavage stages, a steady decrease in zygotic transcript abundance occurs as
development proceeds in the absence of these critical factors. The reduction of Peg3 and Snrpn
is also consistent with the reduction of Nanog and Cdx2 mRNAs, further supporting the
possibility that Sf3b14, Sf3b1, and Rrp7a are required post-transcription during nascent RNA
processing. The loss of Peg3 and Snrpn transcripts in dsRpl7l1 is consistent with the lack of
active Pol II observed in KD embryos.
Figure 10: Transcription and splicing in the absence of Sf3b14, Sfb31, Rpl7l1 and Rrp7a

Assessment of active RNA polymerase II in wild-type and KD embryos at the morula stage (A-E). Quantitative
assessment of Peg3 and Snrnp zygotic transcripts in 8-cell (F) and morula (G) KD embryos. Quantitative analysis
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of multi-exon and single exon transcripts in KD embryos (H). Error bars represent SEM. Asterisks indicate T-test p
values <0.01.

3.3.5 Pre-mRNA splicing in Sf3b14 and Sf3b1 KD embryos
Since Sf3b14 and Sf3b1 are implicated in the splicing of pre-mRNAs, we compared
levels of single exon genes versus multi-exon genes in KD embryos. Previous studies have
shown that defects in splicing machinery can result in specific reduction of multi-exon transcript
abundance (Furumai, R 2010) while single-exon transcripts (that are not spliced) remain
unchanged. To determine if Sf3b14 and Sf3b1 have a role in splicing during preimplantation
embryo development, we assessed expression of additional multi-exon genes as well as several
single-exon genes. Consistent with a role in production of properly spliced transcripts, each of
the multi-exon genes that we examined (n=5) showed significant reduction in both dsSf3b14 and
dsSf3b1 embryos (Oct4, Nanog, Cdx2 in Figure 9K, Peg3 and Snrpn in Figures 10F-G).
However, we do not observe the same drastic reduction in single-exon transcripts. dsSf3b14
embryos show no significant reduction in any of the single-exon genes examined (n=3, Zsr1,
H2be and Fut1, Figure 10I) and dsSf3b1 embryos have reduced H2be, but no reduction of Zrsr1
and Fut1. The consistent reduction in multi-exon transcripts, but absence of reduction in singleexon transcripts supports a role for both Sf3b1 and Sf3b14 in pre-mRNA splicing during
preimplantation development in vivo.
3.3.6 Alternative splicing of the Bcl-x gene
Alternative splicing is the generation of more than one RNA transcript from the same
encoded DNA through the addition or deletion of introns or exons through the post
transcriptional modification termed “splicing”. The advantage of alternative splicing is to create
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more functional diversity of the genome’s 23,000 genes (Chen, L 2012). The prevalence of
genes which undergo alternative splicing was initially estimated to be 35% of all genes
(Mironov, A 1999) and more recently is up to 94% (Wang, ET 2008).
Bcl-x is expressed in 4 different transcripts alternatively spliced based on cell type and
state of apoptosis and is detected in mouse and human preimplantation embryos. The Bcl-x (L)
isoform promotes cell survival whereas expression of the Bcl-x(s) isoform promotes apoptosis
(Perumalsamy, A 2009). Microinjection of the (L) isoform increases mouse embryo survival and
prevents reactive oxygen species (ROS) build up in poor invitro culture conditions (Liu, X 2011)
Knockdown of SF3b1 has been reported to increase the ratio of the apoptotic Bcl-X (s) Bcl-X (L)
isoform over the pro-survival “L” isoform in mouse tissues. (Massiello, A 2006). SF3b1 has
been shown to direct Bcl-X splicing through regulation of the 5’ splice site in the Bcl-x gene
(Massiello, A 2006) by binding to the CRCE 1 DNA element and thereby promoting the
expression of the Bcl-X (L) transcript. Here, we determined if SF3b14, Rpl7l1 and/or Rrp7a
play a role in alternative splicing of this gene.
Gene knockdown was performed as in the previous experiments and in confirmation of
the literature cited above, knockdown of SF3b1 does indeed result in the presence of Bcl-x(s)
splice variant (Figure 11A). Interestingly, knockdown of Rpl7l1 and Rrp7a also produces Bclx(s) (Figure 11.A). Even though SF3b1 and SF3b14 function together in the splicesome for
intron splicing, depletion of SF3b14 does not result in the production detectable Bcl-x (s)
isoform. Although this finding is suggestive of these genes having a role in alternative splicing,
apoptosis could be another reason for the presence of the Bcl-x(s) transcript (Perumalsamy, A
2009). To evaluate apoptosis in our knockdown embryos we assayed 8 cell embryos for p53
using qRT-PCR (data not shown) which results in no significant difference in the relative
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abundance of p53 transcripts although analysis of p53 needs to be performed.

Therefore, these

results suggest SF3b1, Rpl7l1 and Rrp7a may play a role in Bcl-x alternative splicing.

Figure 11: Bcl-x expression in RNA processing knockdown 8 cell embryos

A) Bcl-x (L) and (s) isoform evaluation of 8 cell embryos knocked down with dsGFP or RNA processing genes.

3.4 Conclusions
Here we report loss of function preimplantation phenotypes when Sf3b14, Sf3b1, Rpl7l1
and Rrp7a are functional abrogated. We report detailed embryonic expression patterns and show
that each of these genes is required in the mammalian embryo for the morula to blastocyst
transition. Towards functional annotation of these genes, we document for the first time 1)
essential developmental requirement of Sf3b14, Rpl7l1, and Rrp7a; 2) in vivo nuclear
localization Sf3b14, Sf3b1; nucleolar localization of Rpl7l1; and cytoplasmic localization of
Rrp7a; 3) in vivo data supporting a role for Sf3b14 and Sf3b1 in splicing; 4) in vivo data
implicating Rpl7l1 in initiation of Poll II and/or RNA transcription; and 5) activation of p53
dependent apoptosis in the absence of Sf3b14, Sf3b1, Rpl7l1, and Rrp7a gene function.
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CHAPTER 4
BCOR RNAi INCREASES THE RATE OF PHYSIOLOGICALLY NORMAL
BLASTOCYST FORMATION
4.1 Introduction
Preimplantation embryo development is a dynamic time of development and
differentiation from one cell will arise more than 50 to form the inner cell mass, primitive
endoderm and trophectoderm at the blastocyst stage. In an effort to discover novel genes
required for this intricate process to occur, a reverse genetic screen was initiated to knockdown
individual genes at the one cell stage and evaluate any resultant morphological, epigenetic or
differentiation-based phenotypes.
This report documents the initial characterization of Bcor, Bcl6 corepressor, in
preimplantation embryo development. Bcor knockdown enhances physiological normal embryo
development in murine strains which are known for poor developmental potential. This
improvement is also observed in embryos cultured in hyperoxia conditions. We further
demonstrate that Bcor gene knockdown in bovine IVF embryos improves the prevalence of
blastocysts on day 7 of in-vitro culture which is physiologically normal although no net increase
in the overall number of blastocysts is observed . Taken together, Bcor gene knockdown in invitro conditions increases the rate of physiologically normal blastocysts.
Bcor was first identified as a corepressor of Bcl6. Bcl6 acts through interactions via its
POZ domain which recruit SMRT and NCoR corepressors to bind the SIN3/HDAC complexe in
order to carry out gene repression/activation. Bcor acts by binding to the POZ domain of Bcl6
and by associating to class 1 and 2 HDACs repressing gene transcription in an epigenetic manner
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(Huynh, K 2000). Bcor expression has been observed in the E7.5 ectoplacental cone and is then
present throughout the embryo at E9.5. By E11.5, Bcor expression is found throughout
developing organs of all three germ lineages (Wamstad, J 2007). Bcor gene functions in B-cell
maturationn by association with genes of proliferation and apoptosis regulation (Gearhart, MD
2006).
Human Bcor deletion, frameshift and nonsense mutations present as
Oculofaciocardiodental disease or Lenz microphthalmia syndrome depending on the mutation.
This X-linked affliction initiates during early embryo development affecting eye, face, heart and
tooth development and is only observed in females due to presumed male homozygous lethality
(Ng, D 2004, Horn, D 2005 and Cai, J 2010). Mouse Bcor gene knockdown during tooth
development results in deformities similar to that documented in human mutation demonstrating
a requirement for Bcor gene expression in the dental mesenchyme of E14.5 mouse embryos (Cai,
J 2010). Functional analysis of human Bcor mutant mesenchymal stem cells in vitro demonstrate
increased histone methylation of H3K4 and H3K36 along with increased expression of AP-2α, a
target of Bcor gene repression, resulting in continuous tooth root growth (Fan, Z 2009). Bcor
knockdown mouse ES cells have reduced efficiency for differentiation from pluripotent stem
cells into mesoderm (Wamstad, JA 2008) which is suggestive of a role in the developmental
abnormalities reported above.
We document that Bcor gene knockdown in preimplantation stage embryos enhances
physiological timing of blastocyst formation in multiple mouse strains as well as in hyperoxia
culture conditions. Blastocysts arising from both control and knockdown groups demonstrate
inner cell mass and trophectoderm lineage specification and gene expression. Bcor knockdown
can also increase the prevalence of physiologically normal blastocyst in bovine IVF embryos.
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Taken together, these results suggest Bcor gene knockdown increases physiologically
normal blastocyst development.
4.2 Materials and Methods
4.2.1 Embryo Production and collection
B6D2F1 females (Jackson Laboratories Stock 100006) BALB females (Jackson
Laboratories Stock 000651) DBA females (Jackson Laboratories Stock 000671) received an
intra-peritoneal injection of pregnant mare serum gonadotropin (PMSG; 5 IU/animal), followed
by stimulation with human chorionic gonadotropin (hcG; 5IU/animal) 48 hours later. Mice were
mated with B6D2F1 males. The following morning, females were removed from the stud cages
and examined for the presence of a vaginal plug. If a plug was present, embryos (0.5dpc) were
collected via dissection of the infindibulum with M2 medium followed by 5 minutes in 0.1%
Hyualronidase (Sigma) All animal studies were approved by the Animal Care and Use
Committee, University of Massachusetts.
4.2.2 Microinjection
To create the microinjection needle (injector), borosilicate capillary tubes (Sutter
Instruments) were pulled with a Sutter p-87 glass puller (Sutter Instruments) creating a fine
tapered point. The needle tip was cut to make a 1-2μM diameter opening and the needle was
then bent to 15o using a microforge (DeFronbrun). This needle was back filled with Mercury
and rinsed with 10% PVP (Sigma) prior to use. The embryo holding glass needle (holder) was
created using the same borosilicate capillary tubes and pulled as above, cut at 85μM, fire
polished and bent to 15 degrees. Microinjection was performed using a piezo impact-drive
injector (PrimeTech) mounted on a Diaphot inverted microscope (Nikon) with Hoffman
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Modulation Contrast objectives and condenser. Micromanipulation of embryos was performed
using TransferMan NK 2 (Eppendorf,) in M2 medium (Chemicon) with 0.01% PVP (Sigma).
Each embryo was injected with about 5pL dsRNA. After all embryos were injected, they were
transferred into microdrops of M2 medium for 10 minutes at 37C before deposition in KSOM
medium for extended culture.
4.2.3 Embryo Culture
M2 medium was used for microinjection and embryo extraction. Embryos were cultured
in 35mm petri dishes (Falcon) in 30-50μl drops of KSOM (Chemicon) under 3ml light mineral
oil (Fisher Scientific) in 5% CO2, 5%O2 and 90% N2 at 37oC in a humidified incubator.
4.2.4 dsRNA Production
For T7-RNA polymerase mediated double stranded RNA (dsRNA) production, murine
Bcor, bovine Bcor and Green Fluorescent Protein (GFP) specific PCR primers were designed
using 40 base-pair oligos that contained the T7 binding sequences followed by gene specific
sequences as follows: GFP TAATACGACTCACTATAGGGCACATGAAGCAGCACGACTT
and TAATACGACTCACTATAGGGTGCTCAGGTAGTGGTTGTCG; murine Bcor
TAATACGACTCACTATAGGGAGCTGACCCTGTGATCCAAC

and

TAATACGACTCACTATAGGGGTTCGGTGGTGACACACTTG; bovine Bcor
TAATACGACTCACTATAGGGCATACCCCCACATCCAGAAC and
TAATACGACTCACTATAGGGCTCCAACAGAGGAGGTGAGC;

dsRNAs were created

using the MEGAscript T7 in vitro transcription kit (Ambion) followed by DNase treatment
(Roche) and purification using NucAway Spin Columns (Ambion) and Phenol/Chloroform
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extraction. dsRNAs were re-suspended in Nuclease-Free water (Integrated DNA Technologies)
and diluted to 1µg/µL for microinjection. The dsRNA was stored at -80oC until use.
4.2.5 RNA Quantification
The Agilent RNA 6000 Pico kit was used according to manufacturer’s recommendations.
RNA was extracted from embryos using the High Pure RNA Isolation Kit (Roche) and
resuspended to 1.6 embryo equivalents per microliter (EE/L). . RNA concentration was also
assessed by NanoDrop spectrophotometer according to manufacturers instructions.
4.2.6 RNA extraction and RT-PCR
RNA extraction was performed with Roche High Pure RNA Isolation Kit (Roche).
cDNA was synthesized with both random hexamers and oligo-dT primers as described
previously1.
4.2.7 RT-PCR
RT-PCR was performed using 2 embryonic equilivants per Ruby Taq reactions. Primers
used: B-actin forward AGCAAGCAGGAGTACGATGAGT, Reverse
ATCCAACCGACTGCTGTCA; bovine Bcor forward AGAAGCCAAAGGCAACAGAA,
bovine Bcor reverse
GGATGGTTTCTCGCTGTTGT; Reactions were placed in “My cycler" thermocyclers using
the following thermal profile: 1 cycle of 95C for 1 minutes, then 33 (for β-actin) 38 (for Bcor)
cycles of 30 seconds at 95C and 30 seconds at 60C and 30 seconds at 72oC, and a final cycle of
72oC. PCR amplicons were electrophoresed through a 2% agarose gel at 80V for 45 minutes
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using a Thermo gel box. Bands were illuminated using a Syngene gel doc and band intensity
was quantified with Gene Tools (Syngene software platform).
4.2.8 Quantitative PCR
Real-time RT-PCR was performed using 0.75 embryonic equivalents with Taqman probe
based gene expression assays from Applied Biosystems as follows: 2X Quanta PerfeCTa
Supermix Low ROX, 20X Vic-labeled ActB (#4352341E) or GapD (#4352339E), 20X Gene
Expression Assays (Oct4 Mm00658129_gH; Tead4 Mm01189836_m1; Bcor
Mm00551516_m1) and water to total 20L. Reactions were run in triplicate on a Stratagene
Mx3005p Real-Time PCR machine with a thermal profile of: 1 cycle of 50C for 30 seconds, 1
cycle of 95C for 2 minutes, then 40 cycles of 15 seconds at 95C and 30 seconds at 60C.
4.2.9 Whole mount embryo immunofluorescence
Performed as described (Griffith, GJ 2011). Primary antibodies were used at the
following concentrations: Oct4 sc-5279 Santa Cruz 1:200, Cdx2 AM392-5M BioGenex 1:1000.
Secondary antibodies from Molecular Probes were used at a 1:500 concentration: (AlexaFluor
488 Donkey anti-rabbit A21206, AlexaFluor 546 Donkey anti-mouse A10036
4.2.10 Imaging
Digital images of whole mount embryos and sectioned embryos were taken with a Nikon
Eclipse TE2000-S inverted fluorescence microscope and QImaging Retiga Exi Fast 1394 camera
fitted with a color-slider for use with brightfield images. All slides were imaged with NISElements BR Software.
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4.2.11 Bovine IVF
Oocytes, sperm and media sourced from TransOva Genetics (Long Prairie, MN) kindly
provided in a joint collaboration, were shipped overnight in an incubator shipper at 38.5oC.
After 18 hours post maturation (hpm), embryos were transferred into Fertilization medium along
with sperm at a concentration of 1X106 sperm/ml. for 18hrs. Embryos were gently stripped of
the cumulus layer by aspiration and transferred into SOFaa for 1 hour before injection.
Microinjection was performed using only embryos selected for having a second polar body.
dsRNA was prepared at a concentration of 8ug/ul in nuclease free water prior to microinjection.
Microinjection was performed in holding medium with injections lasting less than 1 hr for both
groups. Embryos were transferred into SOFaa after 2X rinse in SOFaa and cultured in 5% O2,
5% CO2 and 90%N2 until day 8. Media was prepared by TransOva Genetics.
4.3 Results and Discussion
4.3.1 Bcor gene knockdown improves the rate of physiologically normal blastocyst
Single cell B6D2F1 embryos were injected with dsRNA specific for dsGFP or dsBcor
(from now on called dsGFP and dsBcor) followed up to day 4 of development (Figure 12 A-B).
The initial RNAi screen identified Bcor as a failure to make a blastocyst yet upon further
investigation, this proved not to be repeatable (data not shown). While performing the injection
experiments testing the failure to make an outgrowth, we noticed an increase in the amount of
dsBcor embryos making blastocysts 72 hrs post injection (Figure 12 G). To evaluate if this was
a mouse background specific result, we injected dsGFP and dsBcor in the BALB and DBA
mouse strains (Figure 12 C-D) and observed the same trend in the BALB background (Figure
12 H). Performing the same experiment using the DBA mouse strain yielded an increase in day
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4 blasts which although is not physiologically normal in murine embryo culture, is a marked
improvement in DBA blast development. To ensure gene knockdown was successful, we
evaluated Bcor gene expression using qRT-PCR (Figure 12 K) with 8 cell dsGFP and dsBcor
embryos. Gene knockdown was consistently ~20% of dsGFP expression which demonstrating
good gene knockdown. Temporal expression of Bcor throughout preimplantation embryo
development shows a dramatic increase at the 8 cell stage suggesting possible function at this
step in preimplantation embryo development (Figure 12 J). We also note there is no
morphological difference observed at this stage with reduced levels of Bcor.
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Figure 12: Bcor RNAi knockdown in murine embryo development

B6D2F1 (A-B), BALB (C-D) and DBA (E-F) dsGFP and dsBcor knockdown embryo development from 24 to 96
hrs post injection. The overall blastocyst rate of 2 cell embryos for B6D2F1, BALB and DBA (G, H and I
respectively) demonstrate a significant difference in blastocysts being produced on day 3.5 which is physiologically
normal in murine. Temporal Bcor gene expression shows increased abundance at the 8 cell stage (J). Representative
gene knockdown evaluated at the 8 cell stage using qRT-PCR (K). Expression is normalized by GAPDH and to 1
embryo equivalence.
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Although we are able to produce more physiologically normal blastocysts, we need to
determine if these blastocysts are the same quality as in our control group. To assess the quality
of dsBcor embryos, we decided to evaluate lineage specification, the first cellular differention
event whereby an inner cell mass (ICM) and a trophectoderm layer (TE) are formed expressing
mutually exclusive markers. Here, we compared OCT4 (ICM) and CDX2 (TE)
immunofluorescence (Figure 13 A-F) with Oct4 (ICM) and TEAD4 (TE) qRT-PCR (Figure 13
G) for B6D2F1, BALB and DBA background. OCT4 and CDX2 demonstrate successful lineage
specification based on mutually exclusive location of fluorescence. As observed in groups A-F,
there are no instances of cells expressing both Oct4 and Cdx2 therefore lineage specification has
occurred in every group. Based on qRT-PCR, we determine that although there are some groups
with significant differences in gene expression, this observed difference could be due to a change
in cell number in the ICM or TE. As the samples were normalized to 0.75 embryonic
equivalence, a slight change in cell number could alter these results. Interestingly enough, the
changes in gene expression seem to favor pluripotency though more experiments should be done
to verify this claim.
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Figure 13: Lineage specification in dsGFP and dsBcor embryos

B6D2F1, BALB and DBA embryo whole mount immunofluorescence (A-B, C-D and E-F respectively) of OCT4 in
red as an ICM marker, CDX2 in green as a TE marker and DAPI nuclear stain. Based on mutually exclusive
expression, lineage specification has occurred. qRT-PCR of Oct4 (ICM) and Tead4 (TE) show expression of both
markers of lineage specification being produced (G).
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4.3.3 Improved embryo development on day 7 of Bovine IVF
Having determined that physiologically normal embryo development in the mouse is
improved with Bcor knockdown and the resulting blastocysts make ICM and TE with mutually
exclusive markers, we were curious on the practical application of this finding. Since the
embryos which were improved were cultured invitro we decided to evaluate bovine IVF as a
commercial application of this approach as bovine embryo development is between 32 and 50%.
We made bovine specific dsBcor, injected it into 1 cell bovine embryos and followed them
through development. (Figure 14 C-C”). Development to blastocyst was compared to a control
group which was not injected and to dsGFP injected embryos (Figure 4 A-A” and B-B”
respectively). Knockdown of Bcor gene expression was confirmed by RT-PCR and normalized
to bovine β-Actin (Figure 14 D). As was seen in the murine data, the presence of day 7
blastocysts was significantly improved in dsBcor embryos compared to dsGFP (Figure 14 E).
Although there was no significant difference observed between control and dsBcor in terms of
development overall, this could be due to the low number of embryos used in this comparison.
Temporal Bcor gene expression between 2 cell and the blastocyst stage (Figure 14 D) display the
same pattern as seen in the mouse (Figure 12 J) which may suggest a similar role in bovine as in
mouse.
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Figure 14: Bovine Bcor gene knockdown promotes physiologically normal embryo
production

Control IVF embryos which were not injected were evaluated on day 4, 7 and 8 (A-A””) resulting in the production
of blastocysts by day 7. dsGFP and dsBcor injected bovine embryos were also evaluated on day 4,7 and 8 (B-B”
and C-C” respectively). Temporal expression of bovine Bcor in preimplantation development mirrors that observed
in the murine (D). Overall blastocyst rate from all 3 groups result in no overall increase in the number of blastocysts
but does result in an increase of physiologically normal blastocysts on day 7 (E). Bovine Bcor knockdown
evaluated by RT-PCR and densitometer quantification (F).
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4.4 Discussion of results and conclusions
Efforts to improve in-vitro embryo development outcomes have focused on selection of
embryos for transfer based on timing (Sugimura, S 2012, Isom, SC 2012, Reijo Pera, RA 2011)
additives in embryo culture medium (Nquyen, NT 2011, Lott, WM 2011, Maalouf, WE 2009) or
novel culture conditions (Walter, EM 2004). Recently there have been reports of specific gene
RNAi improving embryo culture blastocyst rates or physiological timing. There have also been
studies to determine gene function using RNAi (Matoba, S 2011, Maserati, M 2011, Kawamura
Y 2010).
Here we investigate a gene which when reduced in embryo development, improves the
rate of blastocyst at the correct physiological time and stage; the same time as if it were cultured
in-vivo. This observed improvement encompasses multiple mouse strains, oxygen concentration
differences and species resulting in normal blastocysts which undergo lineage specification.
When evaluating outgrowths in the initial screen, we determined Bcor gene knockdown
does continue at least up to 4 days past blastocyst (data not shown).

Furthermore, since Bcor

has been shown to interact with Polycomb group genes and alter histone methylation (Gearhart,
MD 2006), the epigenetic impact of Bcor knockdown during this dynamic time in development
must be investigated.

To continue this work, one will need to produce dsBcor embryos for

transfer to generate live pups or calves as well as investigate the long term consequences, if any,
of increased histone methylation on live births.
Based on this work we can speculate to some degree on what function Bcor perfoms in
the developing embryo. In Wamstad, JA 2008, stem cells differentiated into a mesodermal
lineage less efficiently in the absence of Bcor. Furthermore, Bcor is known to act as a repressor
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of gene activity working in tandem with Bcl-6 during B-cell maturation. Therefore it is possible
Bcor functions as a repressor of gene function in preimplantation embryo development acting in
a way to ensure embryos which make blastocyst are well suited to continue in development
resulting in offspring having a higher chance of survival.
Depending on species, there are different approaches to guaranteeing survival of
offspring to the next generation. One approach used by insects produce vast quantities of young
without protection leaving only 1-2% of young to survive into adulthood. Mathematically, this
works as 1-2% of thousands still are hundreds which is enough to repopulate the niche they hold.
Mammals use another approach which puts more emphasis on the few live offspring which are
born, ensuring that a much higher percent live into adulthood and here is where I think Bcor fits
into the larger picture. Bcor gene repression helps to weed out weaker embryos ensuring those
which reach the blastocyst stage are the most robust of the group ensuring stronger and more
robust offspring.
Further evidence of this theory is increased housekeeping gene expression in Bcor
knockdown embryos as observed with B-actin and GAPDH. Increased gene expression can lead
to increased rate of cell cycle resulting in a higher cell number at the blastocyst stage. By
ensuring that only the best embryos survive, Bcor confers selective pressure on embryo
development, much like that observed in oogenesis the ovary. Since in-vitro techniques can
reduce this selection pressure but transferring only 1 excellent quality embryo per recipient, the
presence of Bcor in pre-implantation embryo development is not essential.
The improvement in embryo development observed in high oxygen cultures of Bcor
knockdown embryos could also work in hand to reduce the amount of reactive oxygen species
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(ROS) damage. By reducing the rate of cell cycle in high oxygen cultures, the embryo reduces
the amount of DNA exposed to ROS, reducing double strand breaks and the overall possibility of
mutation. In this case, Bcor acts protectively to ensure offspring survival and reduce the rate of
mutation.

If these embryos were in-vivo and elevated amounts of oxygen can be used as an

indication of stress, perhaps Bcor acts to slow or halt pregnancies when the mother is not in the
best condition to be pregnant. In this case, Bcor would work to evaluate the mother’s condition
as an indication of external environmental factors signaling the embryo to grow or to halt.
Perhaps Bcor is involved with cases of spontaneous abortions.
Commercialization of Bcor can benefit many industries such as human and animal
assisted reproductive services. A modest improvement of embryo development would be
welcome in all areas of animal reproduction and financially lucrative.
In order to commercialize this technology, I proposed a 3 phase approach which would
maintain gene knockdown as well as add temporal control. In the first phase, I would re-evaluate
the results from the initial 400 genes and retest those genes which demonstrated no gene
knockdown phenotype. All the individual genes would be knocked down individually in the
B6D2F1 mouse strain and cultured in elevated oxygen as in these embryos it is easier to observe
the embryo recovery and is most cost effective.

Ones which demonstrate a significant increase

in embryo development will be flagged for further evaluation with Bcor in phase 2.
Once these genes have been identified, we would like to test gene knockdown in different
combinations and individually to determine if there is indeed an additive effect. The best
combination of gene knockdown will then proceed to the next phase.
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Phase 3 will require a biochemical partner, preferably a major pharmaceutical to identify
combinations of small molecule inhibitors which can be added to the culture medium for
improved development. These molecules will directly inhibit protein function for so long as the
embryos are in the medium. Once the embryos are removed gene function can return.
I imaging the pharmaceutical will then proceed to use this proprietary mix of small
molecule inhibitors to improve embryo culture medium used in human IVF clinics and in animal
reproductive technologies. There is a high probability one or more large pharmaceuticals would
finance the second and third phase for the exclusive rights to develop the technology for the
clinic as this is a possible new direction for many pharmaceuticals in new drug development.
In order to begin this project, I propose the completion of the Bcor project in
collaboration with InvitroBrasil in Mogi Mirim Brazil. Though this location lacks many of the
essential tools required for manufacturing dsRNAs, the Mager lab contains all required tools and
reagents. The major benefit of using Mogi Mirim is the volume of IVF embryos produced and
the lower cost of embryo transfer and maintaining embryos. Furthermore, there is another
application which would benefit from Bcor gene knockdown. Horse SCNT and ICSI are highly
inefficient because culture conditions have not been optimized for this species. Using Bcor
knockdown in addition to SCNT might increase the rate of physiological normal blastocysts in
sub optimal culture media and allow more embryos to be transferred. Though different dsRNAs
will have to be made, this is a good application for the temporary Bcor gene knockdown.
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APPENDIX A
ADDITIONAL EXPERIMENTS AND FIGURES FOR CHAPTER 2
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A.1. Testing Embryo Pariffin Embedding Protocol

Figure A 1: Sequential sections in embedded embryos in NIH3T3 cells. (Chapter 3)
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A.2. Testimg Embryo Pariffin Embedding Protocol Using OCT4 and CDX2 Antibodies
with OCT4 Knockdown Embryos

Figure A 2: Sequential sections of embedded Oct4 knockdown embryos in NIH3T3 cells.
(Chapter 3). Demonstrates observable gene knockdown in embryos.
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A.3. Testing Pyronin Y Staining Protocol 1

Figure A 3: Relative quantification of RNA in 8 cell embryos based on Pyronin Y staining.
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A.4. Testing Pyronin Y Staining Protocol 2

Figure A 4: Relative quantification of RNA in 8 cell control and Wdr74 gene knockdown
embryos based on Pyronin Y staining demonstrating RNA reduction.
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APPENDIX B
ADDITIONAL EXPERIMENTS AND FIGURES FOR CHAPTER 3
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B.1. 5-MEC staining of 2 cell embryos injected with dsGFP or dsSF3b14

Figure B1: Embryos were stained with anti-5-Mec to determine methylation status as a
previous experiment from Dr Xiangpeng Dai demonstrated a difference. As seen above, no
difference was observed upon repeating the experiment.
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B.2. Antibody Testing SF#B14 from ABGENT in Fixed/Sectioned NIH3T3 Cells

Figure B 2: Initial test of AbGent SF3b14 antibody used in the publication. Using a known
Oct4 antibody, we determined the SF3b14 antibody is very specific and is localized to the
nucleus.
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B.3. Additional Pictures of RPL7LI Knockdown Staining

Figure B 3: Embedded and sectioned embryos were stained with anti Rpl7l1 (Chapter 3)
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B.4. Additional Pictures of RRP7A Knockdown Staining

Figure B 4: Embedded and sectioned embryos were stained with anti Rrp7a (Chapter 3)
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B.5. Additional Pictures of SF3B1 Knockdown Evaluation

Figure B 5: Embedded and sectioned embryos were stained with anti Sf3b1 (Chapter 3)
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B.6. Testing Embryo Pariffin Embedding Protocol Using OCT4 and CDX2 Antibodies

Figure
B 6: Embryo development in simultaneous RNA processing gene and p53 gene knockdown
demonstrating partial blastocyst formation recovery.
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B.7. Gene Knockdown Results of DGCR8 and YY1

Figure B 7: Gene knockdown of YY1, DGCR8 and a combination to determine if YY1
function in embryo development is regulated by microRNAs.
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APPENDIX C
ADDITIONAL EXPERIMENTS AND FIGURES FOR CHAPTER 4
C.1. OXYGEN Knockdown of BCOR in Different Mouse Strains in 5% Oxygen

Figure C.1: Gene knockdown of different mouse strains at the once cell stage on
development to the blastocyst stage. Those strains without error bars were tested one time.
Though there are no error bars the visual increase in number of blastocysts suggest a trend
similar to the statistically significant change observed in DBA and BALB mice.
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C.2. Knockdown of BCOR in Different Mouse Strains in Elevated Oxygen

Figure C.2: Gene knockdown of different mouse strains at the once cell stage on
development to the blastocyst stage. Those strains without error bars were tested one time.
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C.3. Embryo Developmental Images of BCOR Knockdown in DBA Embryos

Figure C.3: DBA embryos development of bcor gene knockdown. 20X
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C.4. Embryo Developmental Images of BCOR Knockdown in Balb Embryos

Figure C.4: BALB embryos development of bcor gene knockdown. 20X
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C.5. Endogenous Expression of Murine BCOR in Oocytes

Figure C.5: Expression of Bcor in B6D2F1 and DBA oocytes normalized to 1 embryonic
equilivance. The results suggest there are
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C.6. Embryo Development of Bovine IVF Embryos Injected with Bovine DSBCOR

Figure C.6: The first set of experiments showing no developmental differences. IVF
medium, supplies and protocols kindly donated by Hong Wei of Transova. Images are of
day 8 embryos taken at 20X.
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C.7. Gene Knockdown of Bovine BCOR Assessment at the 1 cell and 2 cell stage

Figure C 7: In figure C5, there were no observed developmental differences. Here we show
that although we injected dsBcor into these one cell oocytes, knockdown was not observed
at the one cell or 2 cell stage. For the next wexperiments we injected at a concentration of
8ug/ul. Densiometer results normalized by bovine β-actin.
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C.8. Gene Knockdown of Bovine BCOR Assessment at Blastocyst

Figure C.8: In figure C5, there were no observed developmental differences. Here we show
that although we injected dsBcor into these one cell oocytes, knockdown was not observed
at the blastocyst stage. For the next series of experiments we detected Bcor gene
knockdown we injected dsBcor at a concentration of 8ug/ul. Densitometer results
normalized to bovine β-actin.
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C.9. Early BCOR Characterization Data: Endogenous

Preliminary Data:

Preliminary Data:

qRT-PCR panel of Bcor in vivo expression

qRT-PCR panel of Bcor in vivo expression

qRT-PCR Bcor panel of dynamic expression in embryo development relative to Embryo
Equivalence.

MII

1-cell

2-cell

8-cell

Morula

qRT-PCR Bcor panel of dynamic expression in embryo development relative to GAPDH

Blastocyst
MII

1-cell

2-cell

8-cell

Morula

Blastocyst

Water

Figure C.9: Bcor expression between MII and Blastocyst stage embryos was evaluated via
qRT-PCR relative to 0.75 Embryo Equivalence or GAPDH as observed below. Based on
EE evaluation, Bcor expression peaks at the 2-cell and blastocyst stage.
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C.10. Early BCOR Characterization Data: Knockdown Evaluation

Preliminary Data:
qRT-PCR validation of Bcor knockdown expression relative to GAPDH
8 cell

dsGFP

dsBcor

Blastocyst

dsGFP

dsBcor

day 4 outgrowth

dsGFP

dsBcor

Knockdown is observed at the 8 cell stage
Knockdown is still present after 4 days in outgrowth culture

Figure C.10: Gene knockdown observed at the 8-cell, blastocyst and day 4 of outgrowth.
Knockdown at the blastocyst stage looks significantly reduced and may be due to embryo
to embryo variation than actual results.
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C.11. Early BCOR Characterization Data: Development Data

Figure C.11: Temporary Knockdown of Bcor gene expression rescues embryo development
in “poor embryo culture” experiments in DBA. More experiments later show significant
rescue of blastocyst in BALB in later experiments.
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C.12. Early BCOR Characterization Data: Lineage Specification

Figure C. 12: Lineage Day 5 B6D2F1 and BALB dsBcor and dsGFP embryos maintain
lineage specification to ICM and TE.
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C.13. Early BCOR Characterization Data: Lineage Specification

No Primary
dsGFP
Merged

DAPI

Cdx2

Oct4

Figure C.13: Day 5 DBA dsBcor and dsGFP embryos maintain lineage specification to ICM and
TE.
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C.14. Early BCOR Characterization Data: Lineage Specification QRT PCR of DBA
Embryos

DBA 1.26.11 inj

Figure C.14: qRT-PCR of blastocysts selected from each group matched based on relative
appearance. The letter A embryo from the dsGFP group looked similar to letter A from
the dsBcor group ect. They were frozen individually and assessed for relative Bcor, Oct-4
(ICM) and Tead-4(TE) expression.
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C.15. Early BCOR Characterization Data: Lineage Specification QRT PCR of BALB
Embryos

Figure C.15: qRT-PCR of blastocysts selected from each group matched based on relative
appearance. The letter A embryo from the dsGFP group looked similar to letter A from
the dsBcor group ect. They were frozen individually and assessed for relative Bcor, Oct-4
(ICM) and Tead-4(TE) expression.
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APPENDIX D
PROTOCOLS

D.1. Bacterial Transformation
Introduction:
Transformation is the introduction of a plasmid into bacteria. Here, we use chemically
competent bacteria, which allow plasmids to enter the bacterium when heat shocked.
Chemicals/Equipment:
Component

Company

DH5 Competent bacteria
100mm LB-Agar plate
Autoclaved Glass beads
Water bath set to 42oC
SOC

Made here (-80)
Made here (+4)
Made here
Made here

Shaker incubator set at 37oC and 250RPM
Procedure:
1. Thaw DH5 Competent cells on ice.
2. Add 1-2µl of appropriate plasmid and place back on ice for 15 minutes. The control
cells receive NF-H2O
3. Heat shock the cells by placing in the 42C water bath for 30 seconds.
4. Put onto ice immediately.
5. Add 200µl SOC (if no SOC media, you can use LB broth containing no antibiotics)
and place in the 37C shaking incubator for one hour.
6. Make certain of the antibiotic resistance in your plasmid and use the appropriate plate.
Plate out 20-50µl onto one LB using glass beads. Put glass beads onto a plate along with
plasmid/competent cells and shake the plate back and forth to distribute evenly. Check
your plasmid for the antibiotic needed, and make sure we have plates made. NOTE: If
this is for a ligation reaction you can plate out all 200µl. Be sure to always include a
“control” group (no DNA added).
7. Leave in 37C oven overnight. Do not overgrow plates; this leads to satellite colony
formation (which does not contain your plasmid).
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8. Pick individual colonies with a pipette tip and put into tube of 3-5mL LB containing
100 ug/mL of antibiotic and shake at 37C overnight. Again, do not grow for more than
18 hours otherwise you will have overgrown bacteria some of which will not contain
your plasmid. Proceed to miniprep protocol or place in refrigerator.

D.2 Mini-Prep STET Protocol
STET is a quick protocol for isolation of plasmid DNA. Although the resultant DNA
is not as clean as if isolated using the Qiagen Mini-prep kit, it is quite efficient and
inexpensive. This protocol should be used in all plasmid identification experiments.
Component
STET
NF-H20
Lysozyme (10mg/ml) in MilliQ H2O
RNase (1mg/ml) in MilliQ H2O
1.5ml Eppendorf tubes, Autoclaved

Company
Made here
IDT
Thermo Scientific

Catalog #

Axygen

PCR tubes (0.2ml capacity)
Thermo-cycler or 37oC water bath
100% Isopropanol (Kept at -20oC)
70% EtOH in MilliQ H2O

Axygen

MCT-150-C
PCR-0208-FCPC

Fisher

BP2632-4

89833

1. Add ~1.4 ml liquid culture into a 1.5ml Eppendorf tube. Spin at 5000 RPM for 2
minutes. Aspirate the clarified LB medium and repeat if low yields are expected.
2. Make STET Master Mix; add 250ul to each pelleted sample and vortex to resuspend.
Component
STET Buffer
Lysozyme
(10mg/ml)
Rnase A (1mg/ml)

Amount/Sample Location
200µl
miniprep shelf
Green Rnase box, backup in bottom of
40µl
F1
10µl
Green Rnase box

3. Boil for 40 sec. and the liquid in tube turns opaque. Spin full speed for 10 min.
4. Remove pellet with a toothpick and add 160µl of cold Iso-propanol; invert 3 times.
5. Incubate 10 min. at -20oC and then centrifuge 10 min at full speed.
6. Discard supernatant and wash with 300µl 70% EtOH and centrifuge for 5 minutes at
5000 RPM.
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7. Dry pellet completely (~20 min) and resuspend in 30µl of NF- H2O.
8. Nanodrop the re-suspended sample to get the DNA concentration and purity.

D.3 Restriction Digest Protocol
A restriction digest is used to cut specific sequences. Particular restriction enzymes
recognize unique DNA sequences which aid in molecular cloning.
Component
Buffer 10X
Sterile H20
BSA 10mg/ml (100X)
1.5ml eppendorf tubes, Autoclaved

Company
NEB

Catalog #

NEB
Axygen

B9001S
MCT-150-C

PCR tubes (0.2ml capacity)

Axygen

PCR-0208-FCP-C

37oC water bath
1% Agarose Gel

Made here

Gel Electrophoresis chamber
UV imaging

In Mager lab

Bluescript plasmid map.
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Introductory notes:
1. Restriction enzymes are supplied in Units. 1U is defined as the amount needed to
completely digest 1µg of DNA in one hour.
2. Always keep enzymes on ice. The activity of these expensive enzymes will
diminish quickly if allowed to alternate between -20oC and Room Temperature
3. All samples which use 2 enzymes must be run with the single cut as well for
troubleshooting purposes. For example, if using HindIII and EcoRI on the same
sample, cut once with HindIII, once with EcoRI, once with both and then uncut.
All 4 will be run individually to ensure each enzyme cuts as expected. Always
run uncut plasmid DNA as a control.
4. Restriction endonucleases (RE) have different levels of cutting activity depending
on the 10X buffer used. For example, HindIII has 100% activity in buffer 2 and
50% in buffers 1 and 4. If HindIII is used in buffer 3, it will only display 10%
activity. Choose your buffers carefully using the attached double digest chart.
D.4 Analytical Restriction Digest
a. Once the best buffers/enzyme match has been chosen, make a master mix.
Each sample will be digested in 10 ul total.
Per Sample
10X buffer
1.0 ul
10X BSA*
1.0 ul
enzyme^
0.5 ul
add the appropriate amount of water to 9.0 ul
* BSA is optional depending upon the enzyme used.
^ it may be more appropriate to add your enzyme after making a mastermix of
the other listed components.
2. Carefully label eppendorf tubes with the sample number and enzyme to be used.
3. Add 9µl of the master mix to each tube.
4. Add 1µl DNA (at least 200ng/ul, if less than you need to use more DNA and
adjust the mastermix).
5. Incubate the samples for 15 minutes-1hour at their optimal activity temperature.
Usually this is 37oC but some enzymes work better at other temperatures
(Sma1 25oC)
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6. Run samples on a 1% Agarose gel (gel electrophoresis protocol) to observe
plasmid fragment size.
D.5 Hemacytometer (Cell Counting)
Resuspended cells can be counted for exact seeding densities. Hemacytometers use a fine
grid etched in the bottom of a glass/quartz chamber to count cells within 1cc.

Procedure:
1. Resuspend cells into a known volume
2. Place the quartz coverglass over the counting grid. Be certain to cover the two
edges which seal the coverglass to the grid when the sample is loaded.
3. Add exactly 10ul or a well mixed sample to the notch of the hemacytometer.
4. Let the cells settle and count the center grid. NOTE: Do not count cells over the
left and upper most border.
5. Multiply that number by 104 to calculate the number of cells/ml.
6. Multiply by the known volume. This is the total amount of cells you have in
suspension.

For example: If one counts 64 cells in the center grid, that equals (64)(104) or 640,000
cells/ml. If you have resuspended your cells in 10ml, you have (6.4X105)(10) or 6.4X106
total cells.
D.6 Streaking Bacteria on Plates
Bacteria are streaked out on LB-agar plates to isolate single colonies.
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Component
LB-Agar plates
p200 pipettor or bacterial inoculation loop
p200 tips
37oC dry incubator (on floor in rm 301)

Company
Made here; stored at 4oC

Catalog #

Before you begin:
1. Always perform bacteria/plasmid based protocols in the designated areas.
2. Wear gloves and practice sterile technique.
Procedure:
1. Investigate the plasmid transformed into the bacteria stock you will be streaking
out. Ensure the antibiotic resistance of the plasmid matches the antibiotic added
to the LB-agar plate.
2. Label the LB-Agar plate with:
a. Plasmid #
(for example)  #1
b. Plasmid name
FUG-Exm2
c. Your initials
MM
d. The date
09.18.09
3. Find the frozen bacterial stock located in the -80oC freezer. Quickly scrape a
visible quantity onto your p200 tip and gently scratch
the top of the LB-Agar making as slight impression as
possible. Return stock to -80oC ASAP. An
inoculation loop/flame may be used as well flaming
and cooling before extending a new streak.
4. Eject your tip, attach a fresh tip and proceed to streak
once over the first area and continue the streak line to a
sterile area of the plate.
5. Continue this cycle 3-4 times, streaking only once through the previously streaked
area and continuing through to a sterile area.
6. Place the streaked LB-Agar plate inverted in the 37oC bacterial incubator
overnight or for a minimum of 12 hours; until colonies appear.
7. Store the bacterial plate, inverted/ wrapped in parafilm at 4oC for up to 1 month.
D.7 Immunofluorescence of Pre-Implantation Stage Embryos
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Procedure:

Use:

1. Fixation: 4% PFA for 30 minutes at room temperature.

Depression wells

2. Wash embryos 3X in PBT. 2-3 min/well

Depression wells

3. Permeablization: Place embryos into 0.5% Triton X-100 PBS 20-30 min
Depression wells
4. Wash embryos 3X in PBT. 2-3 min/well

Depression wells

5. Block: 2% BSA in PBS for 1 hr at RT
Microdrop dish
6. First Antibody: 1hr at RT or 4oC overnight. Antibody added to 2%
Microdrop dish
BSA in prescribed ratio. Embryos aspirated through 3 drops.
7. Wash embryos 3X in PBT. 2-3 min/well.

Depression wells

8. Second Antibody: 1hr at RT. Antibody and 1:100 DAPI added to 2%
Microdrop dish
BSA in prescribed ratio. Embryos aspirated through 3 drops.
9. Wash embryos 3X in PBT. 2-3 min/well.

Depression wells

10. Mount embryos in 2.5uL water and cover with number 1 coverglass.
NOTE: Add sufficient Vaseline to prevent embryo flattening.
Mount embryos in VectaShield if imaging with the ApoTome.
Seal the edges of the slide with nail polish.
Store at 4oC, image ASAP!
Media:
4% PFA:
Add 4g PFA to 100ml PBS.
Heat to 56oC until in solution.
Aliquot 1ml/1.5ml eppendorf tube.
Store at -20oC until use.
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Glass Slide

0.5% Triton X-100:
Add 25uL Triton X 100 to 5 ml PBS
Gently rock for 20 minutes until in solution.
Make and use the same day; can be stored in the dark overnight.

0.1% Tween-20 PBS (PBT):
100ul Tween-20 into 100 ml PBS w/o Ca Mg
Mix well.
Store at RT

2%BSA Block and antibody solution.
Add 2g BSA over 100ml PBS.
Do not mix. Allow BSA to fall into PBS ~20min
Aliquot 1 ml into 1.5ml eppendorf tubes Store at -20oC

104

D.8 Making Glass Injection Tools
These tools are used to inject dsRNA and other liquid based molecules into the cytoplasm of 1
cell embryos. These tools can also be adapted to be used for PN injection of DNA.

Component
Borosilicate glass
Micropipet puller
Microforge
Mercury/elemental

Company
Sutter
Sutter
Defronbrune
EHS (recycled 3X distilled)

Catalog #
B100-75-100
P-97

Before you begin:
1. Ask permission of the Fissore lab to use the
2. Wear nitrile gloves and handle mercury within the chemical safety hood.
Procedure:
1. Pull the pipets
a. Insert a single pipet into the P-97 puller making sure both sides are equal
in distance apart. There are black marks to align the needle.
b. Load program 95 or 79 (same) and press the green button. The
parameters for this code are “ Heat 790, Pull 50, Vel 45, Time 210”
c. The pipet is then removed and is ready for cutting.
2. Cut and bend the pipet
a. The pulled glass pipet is loaded onto the metal spring loaded holder
mounted on the right side of the light source.
b. Using the size chart located on the front right of the DeFrombrune
microforge machine, bring the needle into position using the adjustemnet
knobs on the left and right of the light source.
c. The heating element (platinum wire with a glass bead) should be located
over the glass pipet which is coming in from the left through the oculars.
In reality, the image through the oculars is inverted so with your eyes
looking at the heating element directly, the needle should come from the
right and be over the heating element.
d. For injection needles the pulled pipet is cut at ~1-2 uM in diameter. This
area though difficult to measure under 10X is easily seen as the first area
behind the point that has a green sheen on the glass. Set the heat to ~7 and
lower the glass to touch the pipet. Immediately turn off the heat and the
needle will break in a perfect cross section.
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e. Push the needle forward 1-1.5 cm using your finger and heat the element
to bend the point up (observed thought the oculars). The needle is finished
and is ready for Mercury and use.
f. Mercury is located in the chemical fume hood in the Fissore lab. Wearing
Nitrile gloves (not latex) aspirate a small amount of mercury in the 1cc
syringe with the spinal needle attached. Place no more than 1 cm
mercury in the needle towards the large open end. You want the mercury
to connect to the water or oil in the cell tram oil without air bubbles. Put
the needle into a covered container for immediate use.
g. Discard in Mercury waste located in the Fissore lab fume hood.
h. For holding needles, measure for ~100uM and cut as above in step “d”.
Fire polish tip to an opening of ~ 60uM. This is done by inverting the tip
to be located directly over the heating element. Activate the heat and
watch the tip of the holder begin to close. Using the measuring device in
the oculars, stop the heat when the tip opening approaches 60uM. Return
the needle to the horizontal position push the tip forward 1-1.5 cm. Bend
the needle to 15%.
i. Discard holder in sharps container after use.
j. Store in a closed container at RT.

D.9 Embryo Injection of DSRNA
This protocol describes all events which need to take place for microinjection of dsRNA in 1 cell
oocytes.
dsRNA
1. dsRNA is designed using the PRIMER 3 program using unique 21mer sequences to that
gene. Searching the known genome of the species to be used should be done prior to making
dsRNA.
2. Send sequences to IDT complete with the T7 primer attached.
3. Do a PCR using cDNA from the species of interest.
a. PCR:
i. Add 25 μl Ruby Taq, 1.25 μl of each primer (forward and reverse) as well as
5-10 μl cDNA. Fill to a total volume of 25 μl Cycle in MyCycler
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Thermocycler to specifications based on the melting temp of the primers used.
As a default, I find 35 cycles at 57-60 degrees Centigrade over 35-45 cycles
will produce enough T7DNA template for all injection experiments.
ii. Take 1ul of the unpurified product and run on a gel to verify expected
amplicon size. 1% agar gels at 80V for 35-40 minutes will work well.
b. Purification:
i. Purify the product using the PCR purification kit from Qiagen. After
purification, adjust the concentration of the T7DNA to 40 ng/μl.
4. Making dsRNA (In-vitro Transcription)
a. Using the MEGAscript Kit, add the following to a 0.2 μl PCR tube: 1 μl ATP
solution, 1 μl CTP solution, 1 μl GTP solution, 1 μl UTP solution, 1 μl 10 X buffer, 4
μl T7DNA and 1 μl enzyme. Always run a T7GFP control.
b. Wrap the tubes with parafilm and place them (designed T7DNA and T7GFP control)
into an incubator set at 37 degrees C for 16-24 hours. The water bath is not as
efficient and can introduce contamination. Do not place tubes on ice after in-vitro
transcription!
c. Run 0.5 μl of the product on a 2% gel to verify the dsRNA size.
5. DNAse treatment:
a. add 9.5 μl in-vitro transcription product and 0.5 μl DNAse (from kit). Mix by
flicking the tube and then place at 37 degrees centigrade for 30 minutes.
6. NucAway spin column purification:
a. Add 650 μl NF water to each tube. Vortex for 30 seconds and tap the end of the tube
on the table to free the air bubbles.
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b. Remove the bottom stopped and centrifuge excess liquid into a 2 ml collection tube
and spin at 750 g for 2 minutes. The tube is ready for use.
c. Place the column into a 1.5 ml collection tube. Add 20-100 μl sample to top of tube
and spin for 750 g for 5 minutes. Your purified sample is located in the collection
tube
7. Phenol/Chloroform extraction:
a. Adjust the volume of the sample to 200 μl with NF-water.
b. Add 200 μl Phenol/Cholorform/isoamylalcohol to tube. Vortex for 15 seconds.
c. Centrifuge at maximum (~13,000 g) for 10 minutes.
d. Transfer upper phase to new 1.5 ml eppendorf tube containing 200 μl chloroform.
Vortex for 15 seconds.
e. Centrifuge at maximum (~13,000 g) for 10 minutes.
f. Transfer 200 μl upper phase to new 1.5 ml eppendorf tube containing 20 μl 3M
sodium acetate . Vortex for 15 seconds.
g. Add 660 μl ice cold 100% EtOH. Place tubes into -20 (4 hrs) or -80 (40 minutes)
centigrade freezer.
h. Centrifuge at maximum (~13,000 g) for 20 minutes.
i. Rinse pellet with 70% EtOH. Spin for 5 minutes max speed.
j. Remove supernatant and allow the tubes to dry invered on a kimwipe for 30 minutes.
k. Resuspend dsRNA with 10 μl NF-water
l. Determine concentration of dsRNA using a nanodrop photospectrometer. Adjust the
concentration to 1ug/μl. Aliquot 5 μl/tube. Store at -80 degrees centigrade.
8. Injection of 1 cell mouse embryos
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a. B6D2F1 mice (B6 X DBA F1 8-12 weeks old) are superovulated with 10 IU PMSG
followed by 10 IU hCG 48 hours later and mated with a stud male. Embryos are
collected via discetion in M2 medium and transferred to 50 μl microdrops under oil
prior to injection.
b. Prepare KSOM microdrops for embryo culture at least 3 hours before beginning the
experiment.
a. Add 7-8 ~25-30ul drops of KSOM into a 35mm petri dish overlayed with
3 ml mineral oil.
b. Prepare 3 dishes per experiment to ensure enough for each group.
2. Set the needle for microinjection
a. Once the injection needle has been back loaded with mercury, attach the
needle to the piezo pipette holder ensure all air has been removed.
b. Gently advance the mercury towards the tip while positioned over a 35mm
dish containing a microdrop of 10% PVP overlaid with mineral oil.
c. Under the 4X objective adjust the needle until you see it over the drop and
move it into view. Use the PVP drop as a point of origin.
d. Once the mercury is at the tip, place the needle in the PVP drop and
aspirate to fill the tapered aspect of the needle. Leave it overnight.
Day of experiment:
1. Remove the embryos from the mice oviducts.
a. Prepare the mice by cervical dislocation the plugged mice, open the mice
ventrally, and cut out the oviducts.
b. Remove the embryos by ripping the bulge in the oviducts containing the
embryos.
c. Collect all embryos via a P200 placing them in Hyaluranidase/M2 for 3
minutes at 37 degrees C.
d. Rinse embryos through sequential M2 drops until there are no cumulus
cells; about 5 (30ul) drops.
e. Rinse embryos through one drop of KSOM and place into another KSOM
drop until injection.
2. Arrangement of the plate:
a. Petri dish: Invert the cover and use this to microinject upon. The reduced
side height lends to better clearance of the injector and holder giving one
more area for adjustment.
b. M2/PVP- Add 400ul M2 and ~5uL 10%PVP into a 1.5ml eppendorf tube.
Vortex briefly. Add 200ul of this mixture to the inverted top of a 100mm
petri dish (Optilux is preferred but just any petri dish cover will due as
long as it’s flat, clean and sterile.
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c. dsRNA- Previously made and frozen at -80, thaw at RT, add 0.4ul of
dsRNA to each group. Except in rare occasions, every experiment will
include dsGFP as a control.
d. 10%PVP- Add 15-25ul 10% PVP to the plate in order to better lubricate
the injector needle.
e. Mineral Oil- Once all drops are placed using the suggested orientation on
the next page, overlay the dish with Mineral oil to prevent evaporation.

NOTE:Overlay with mineral oil
3. Setting up the holder and initiation of microinjection.
a. Place the microinjection plate on the Nikon Diaphot inverted microscope.
b. Carefully add the mercury filled injector to the piezo ensuring no air
bubbles are present between the mercury and the oil. Tighten until snug.
c. Place the injector on the right micromanipulator arm. Do not
adjust/tighten the clip as slight movement is required for the piezo to work
properly.
d. Viewing through the inverted microscope at 4X, move the 10% PVP drop
into range. Adjust the focus until the edge of the drop is in crisp focus.
This will be your point of reference setting up your injection tools.
e. Now switch your gaze from the oculars to the micromanipulation arm
holding the piezo and injection needle. Move the manipulation arm so as
the tip is over the drop. Adjust the angle of the needle so as the tip end is
parallel to the plate.
f. Blow out all the air. Now move the needle into the drop while viewing it
from the oculars on the microscope. You should see the shadow from the
needle as it comes into view. Keep moving the needle down until it is
clearly visible.
g. Do the same for the holder
h. Rinse needle in 10% PVP and keep in PVP until ready for microinjection.
4. Microinjection
a. Aspirate dsGFP into the injector. Aspirate 2-3 complete turns over 2
minutes time to fill the injector.
b. Reverse flow until the dsRNA is coming out very slowly. Evaluate this
flow in the 10% PVP drop only.
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5.

6.

7.

8.

c. Load a group of 10-50 1 cell embryos into the injection drop rinsing in M2
1X prior.
d. One by one, collect the embryo with the holder. Pull the embryo into the
holder as seen in figure 1 in the text. Place the injector inside the holder
and activate the piezo to lyse the oolemma and inject the dsRNA. Once
the secondary chamber is filled, remove the injector and load another
oocyte. Inject the entire group waiting 5 minutes to transfer into KSOM
for culture.
e. Evaluate culture daily and record development.
Cryopreservation of embryos:
a. Rinse embryo(s) in 0.3% PVP PBS 3X.
b. Place in 1.5 ml eppendrof tube with minimal medium
c. Place immediately into liquid nitrogen
d. Store in -80 degree centigrade freezer until use.
Isolation of RNA from frozen of fresh samples
a. Thaw embryo samples and add 200 μl PBS. Add 400 μl Lysis/Binding
buffer (green cap)
b. Prepare a High Pure Filter placing it into a collection reservoir.
c. Add entire sample and centrifuge 15 sec at 8000 g
d. Cut caps off filter unit and discard flow through liquid.
e. Add 90 μl DNAse to sample and keep at RT for 15 minutes.
f. Add 500 μl wash buffer I and centrifuge 15 seconds at 8000 g
g. Remove flow though, add 500 μl wash buffer II and centrifuge again 15
seconds at 8000 g
h. Remove flow through and add 200 μl wash buffer II. Centrifuge at
maximum (13,000 g) for 5 minutes.
i. Remove collection tube replacing it with a fresh 1.5 ml eppendrof tube.
j. Add 30 μl NF-water, wait 2 min. and then centrifuge 1 minute at 13,000 g
k. Store eluted RNA at -80 degrees centigrade until use.
Making cDNA of embryo samples:
a. Thaw RNA samples (or use fresh from above protocol) adding 8 μl of
qScript reaction mix and 2 μl of qScript RT enzyme.(qScript cDNA
Synthesis kit)
b. Mix by flicking the tube and place inside thermocycler using the following
protocol to heat the tube and activate the RT to transcribe cDNA: 1 cycle
at 22 degrees centigrade for 5 minutes; 1 cycle at 42 degrees centigrade
for 30 minutes; 1 cycle at 85 degrees centigrade for 5 minutes and then
off. Do not put on hold for 4 degrees centigrade as it can damage the
thermocycler over prolonged periods of use.
c. Store at -20 degrees centigrade until use.
qRT-PCR evaluation of samples
a. Performed in triplicate of 20 μl volumes, use the serial pipettor to make
the solution concentration the same in each tube.
b. Calculate how many embryo equivalents (EE) you need to run per sample.
For instance if the tube you just made cDNA originally held 40 embryos
and your final volume of medium is 40, you already are at 1 embryo
111

c.

d.
e.
f.
g.

equivalent per μl. If you had only 10 embryos then you will be at 4 μl per
embryo equivalent. (volume/number of embryos = EE). For convienence
sake, reactions are run at 1EE/ μl.
Calculate (1) 20 μl reaction by listing the following: 10 μl 2X master mix,
1 μl normalizing primer (GAPDH or β –actin) 1 μl gene expression
primer, 1 EE sample (1-8 μl) with the balance of NF-water.
Add 3X per tube and make up a master mix with all parts except DNA idf
you are testing different samples.
Carefully aliquot samples into 3X tubes.
Put into 3000mx cycler and input parameters based on primer melting
temps.
Run samples and analyze data
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